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STUDY OF ROLE OF RIBOSOMAL PROTEIN L13A IN RESOLVING
INFLAMMATION
DARSHANA PODDAR
ABSTRACT

Inflammation is an obligatory attempt of the host immune system to protect the body
against infection. However, unregulated synthesis of pro-inflammatory products can have
detrimental effects. Though mechanisms which contribute to inflammation are well
appreciated, those that resolve inflammation are poorly understood. Therefore,
understanding the molecular basis of such pathways will provide an entirely novel
approach to treat and prevent inflammatory diseases. Transcript-selective translational
control can regulate the expression of a set of inflammatory genes. We have identified
one such mechanism in a novel animal model which relies on the abrogation of ribosomal
protein L13a-dependent translational silencing by creating macrophage-specific L13aknockout mice where resolution of inflammation is severely compromised. We have used
these knockout mice to study two different kinds of inflammation: LPS induced systemic
inflammation and dextran sodium sulphate (DSS) induced experimental colitis. Upon
LPS induced endotoxemia, these mice displayed high mortality rates and severe
symptoms of inflammation such as infiltration of immune cells in the peritoneum and
major organs leading to tissue destruction. These animals also exhibited high serum
levels of TNF-α, blood urea nitrogen (BUN), aspartate aminotransferase (AST) and
several other markers of inflammation. Macrophages from these knockouts showed
unregulated synthesis of several chemokines (e.g., CXCL13, CCL22, CCL8 and CCR3)
and increased polysomal abundance of these mRNAs due to the abrogation of their
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translational silencing. Upon DSS induced colitis, these knockout mice demonstrated
higher susceptibility to colitis displaying reduced survival, significant weight loss,
enhanced rectal bleeding and diarrhea. Histopathology analysis of tissue sections from
the knockouts showed disruption of epithelial crypts in the colon with infiltration of
macrophages in colon and spleen sections. Additionally, elevated levels of several
chemokines and cytokines were found to be associated with the serum and colons of the
DSS administered knockout animals. Therefore, based on these observations, we
hypothesize that L13a-dependent translational silencing has evolved as an endogenous
defense mechanism in monocytes and macrophages against uncontrolled inflammatory
response and disruption of this pathway can severely impair the resolution phase of
inflammation.
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CHAPTER I
INTRODUCTION

1.1. Inflammation and overview of inflammatory response

Inflammation is an adaptive response generated by the immune system upon
stimulation by destructive conditions and inflammatory assaults like infection and tissue
injury (Majno and Joris, 2004, Medzhitov, 2008). Despite the cause, an inflammatory
response is initiated with the goal of restoring tissue homeostasis. Inflammation governs
diverse physiological and pathological processes. Though research over the past couple
of decades have highlighted the importance of inflammation in the context of
pathogenesis of several inflammatory diseases, it is essential to understand and appreciate
the physiological functions of inflammation as well. It is generally considered that a
regulated and balanced inflammatory response is beneficial to the host; but at the same
time a dysregulated response can result in an autoimmune attack and prove to be lethal
for the host. At the initial stage, an inflammatory condition is induced by infection or
tissue injury which activates the primary mediators which are the body’s immune cells.
The activation of these immune cells is followed by coordinated and precise recruitment
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of these cells (plasma cells, lymphocytes and leukocytes) to the sites of infection or
injury (Majno and Joris, 2004, Medzhitov, 2008). Microbial (bacterial and viral)
infections are recognized by the body’s innate immune receptors like the Toll-like
receptors (TLRs) and NOD (nucleotide-binding oligomerization-domain protein)-like
receptors (NLRs) and the cytosolic RIG –I (retinoic acid inducible gene 1) like receptors
(RLRs) (Medzhitov, 2008, Barton, 2008). This elementary recognition of infection is
carried out by the tissue resident macrophages and mast cells which subsequently results
in the synthesis of various pro-inflammatory molecules like cytokines, chemokines,
vasoactive amines, eicosanoids etc., to mediate the inflammatory response. This is then
followed by selective extravasation of the neutrophils from the bloodstream to the
distressed tissue sites where they release the toxins from their granules to kill the
pathogen (Medzhitov, 2008, Nathan, 2006). The toxins cannot distinguish between the
foreign pathogen and the somatic cells thus leading to substantial tissue damage (Nathan,
2002). If a favorable acute inflammatory response is able to eliminate the foreign
pathogen, then it is followed by the resolution phase where there occurs restoration of
tissue homeostasis and extensive tissue repair by the tissue resident and recruited
macrophages (Serhan and Savill, 2005). However, if an acute response fails to remove
the pathogen, then an adaptive response is generated where the T cells and the
macrophages come into play leading to a chronic inflammatory state. A chronic
inflammatory state can also be triggered in response to persistent self antigens or due to
malfunctioning of the tissue itself or due to loss of homeostatic equilibrium of some
biological processes that are not directly related to host defense or tissue repair (Figure 1)
(Medzhitov, 2008).
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Figure 1. Causes, physiological and pathological outcomes of inflammation. Depending on
the stimulus, inflammatory response can have different physiological purpose and pathological
outcomes. Of the three possible inflammatory triggers, only infection-stimulated inflammation
can be associated with an immune response. Tissue damage and stress on the other hand can
promote a chronic inflammatory state and autoimmune diseases. Figure 1 has been adapted from
figure 1 of “Origin and physiological roles of inflammation.” Medzhitov, R. 2008. Nature. 454:
428-435.

1.2. Macrophage-mediated inflammation and disease
Macrophages are primitive cells existing in the metazoans and primarily identified by
their phagocytic nature. They are present in all tissues where they demonstrate
anatomical and functional diversity (Wynn et al., 2013). Macrophages can be described
as terminally differentiated mononuclear phagocytic cells derived from the circulating
monocytes that originated in the bone marrow but they may have different lineages as
well (Wynn et al., 2013). Macrophages can be classified on the basis of their
3

inflammatory states which include the classically activated and the alternatively activated
macrophages (AAMs) designated as M1 and M2 respectively. Activation of these two
sets of macrophages depends on response to interferon-gamma (IFN-γ) and toll-like
receptors (TLRs) or to interleukin-4 (IL-4) and IL-13 respectively (Gordon, 2003, Sica
and Mantovani, 2012). Macrophages participate in a variety of biological processes in an
organism starting from development, tissue homeostasis and wound healing to immune
responses to microbial invasions. The tissue resident macrophages act as guards to
regulate tissue homeostasis and this process may also lead to recruitment of macrophages
from circulating monocytes, spleen and bone marrow or local proliferation (Jenkins et al.,
2011, Schulz et al., 2012). However, sometimes wound healing and tissue homeostasis
may not be restored due to residual persistent inflammatory assault and in that scenario
macrophages can be leading causes of several inflammatory diseases like cancer, obesity,
diabetes, atherosclerosis, inflammatory bowel diseases etc.
During tissue damage after invasion by foreign pathogens, Ly6C+ inflammatory
peripheral blood monocytes are recruited from circulation to the sites of tissue injury
where they differentiate into macrophages. These macrophages then secrete several proinflammatory molecules including tumor necrosis factor alpha (TNF-α), IL-1 and nitric
oxide (NO) which then activate several downstream anti-pathogenic defense mechanisms
(Wynn et al., 2013). These tissue recruited macrophages also secrete other cytokines like
IL-12 and IL-23 which help in the expansion of TH1 and TH17 cell subsets to further
control the infection and eliminate the pathogen (Sica and Mantovani, 2012). Although
synthesis of pro-inflammatory products is an obligatory attempt of the macrophages and
monocytes to mediate inflammation, uncontrolled accumulation of these molecules may
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be toxic to the host. Release of the cytokines and chemokines by the macrophages and the
reactive oxygen species synthesized by the T cells during tissue injury often leads to
considerable damage to the surrounding tissue (Nathan and Ding, 2010). If this
inflammatory macrophage response is not checked in a timely manner, it can be causal in
the initiation and progression of several chronic inflammatory and autoimmune diseases
(Sindrilaru et al., 2011, Krausgruber et al., 2011). In order to neutralize the excessive
tissue damage response, these activated macrophages sometimes undergo apoptosis or
even change to a suppressive phenotype to promote tissue healing (Murray and Wynn,
2011b). Therefore, it can be said that switching of macrophages from an inflammatory
state to an anti-inflammatory or suppressive sub-type and back to a pro-inflammatory
phenotype can be vital in the pathogenesis or resolution of many chronic inflammatory
diseases (Figure 2).
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Figure 2. Macrophages that have unusual activation profiles have essential functions in
regulating disease progression and resolution. Macrophages are highly fexible cells that
exhibit different activation states (CAMs, PFMs, AAMs and Mregs) based on different
environmental stimuli. During a pathogenic attack or associated tissue damage, the local resident
macrophages assume an “inflammatory phenotype” and are then known as Classically Activated
Macrophages (CAMs). These macrophages are activated by IFN-γ and then activate the STAT1
and NFκB signaling pathways. This in turn increases the production of several inflammatory
cytokines like IL-1, IL-6, TNF-α and reactive oxygen or nitrogen species. These molecules then
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promote anti-tumorigenic and anti-microbial immunity and also insulin resistance and obesity. On
the contrary, some of the epithelium-derived sentinels produce type 2 cytokines like IL-4 and IL13 which activate the “alternative” state of the macrophages (AAMs) which are primarily
engaged in wound healing and promoting fibrosis and insulin sensitivity. They also activate the
wound healing pro-fibrotic macrophages (PFMs) which produce several growth factors such as
TGF-β1, VEGF and PDGF which activate myofibroblasts and help in collagen synthesis. AAMs
also synthesize a variety of Immunoregulatory proteins like arginase 1 (ARG1), RELM-α and IL10 which monitor the magnitude and span of an immune response. The AAMs also scavenge
collagen and other extra-cellular components (ECM) therefore aiding in ECM remodeling. Thus
where CAMs are responsible for eliciting an immune defense response, the AAMs are primarily
involve in immune suppression and restoring tissue homeostasis. The regulatory T cells (T regs)
secreting IL-10 and the engulfment of apoptotic debris selectively increases the population of
regulatory macrophages (Mregs) that suppresses inflammation and facilitates anti-tumorigenic and
anti-microbial defense. Figure 2 has been adapted from Figure 4 of “Macrophage biology in
development, homeostasis and disease.” Wynn, T. A., Chawla, A. and Pollard, J. W. 2013.
Nature. 496: 445-455.

1.2.1. Role of macrophages in inflammatory diseases
Macrophages play important roles in the pathogenesis of several inflammatory
diseases like cancer, asthma, atherosclerosis, rheumatoid arthritis, inflammatory bowel
diseases, endotoxemia and fibrosis. Previously it was believed that macrophages are antitumorigenic but recent studies have implicated the role of macrophages in tumor
initiation, progression and metastasis (Qian and Pollard, 2010). Macrophages synthesize
several pro-inflammatory cytokines like TNF-α, IFN-γ and IL-6 which sustain the
chronic inflammatory response thereby facilitating tumor initiation and progression
(Balkwill and Mantovani, 2012). Asthma is a chronic inflammatory disease characterized
by inflammation in the airway tract, airway obstruction and lung remodeling. The
pulmonary macrophages produce a variety of cytokines like IL-4, IL-13 and IL-33 which
7

stimulate pulmonary smooth muscle contractions and degradation of the extra-cellular
matrix (ECM) leading to pathogenesis of asthma (Gordon, 2003). Atherosclerosis is a
process that initiates with the activation of the resident macrophages of the vessel wall
triggering the adhesion of leukocytes to the endothelium. These adhered leukocytes then
extravasate through transendothelial space in response to a chemotactic gradient. These
processes are regulated by the coordinated action of many different chemokines and their
cognate receptors (Zernecke and Weber, 2010, Golledge, 2013, Mukhopadhyay, 2013).
Macrophages secrete several inflammatory cytokines like TNF-α, IL-12, IL-18 and IL-23
that play critical roles in triggering autoimmune diseases like rheumatoid arthritis
(Murray and Wynn, 2011a). Macrophage derived IL-23 has been studied to promote endstage joint inflammation whereas TNF-α has been shown to promote polyarthritis via
macrophage and dendritic cell secreted IL-12 and IL-18. Macrophages have been shown
to play essential roles in contributing to the pathogenesis of inflammatory bowel diseases
(IBDs). IBDs are thought to be caused by an imbalance between the commensal bacteria
and the host’s immune system leading to mis-functioning of the immune cells and
infiltration of macrophages and other leukocytes into the colon mucosa. Studies have
shown that a group of TLR2+ CCR2+ CX3CR1int Ly6Chi GR1+ macrophages induce
colonic inflammation by producing large quantities of TNF-α (Platt et al., 2010). Recent
finding also suggest that the inflammatory cytokines and reactive oxygen species
generated in the colon can transform the anti-inflammatory macrophages to the proinflammatory dendritic cell like cells which secrete large amounts of IL-12, IL-23 and
nitric oxide synthase thereby promoting colitis (Rivollier et al., 2012). On the contrary,
recruited monocytes and tissue resident macrophages also help in clearing out the

8

apoptotic cells and debris thereby allowing wound healing and epithelial cell repair. Thus
macrophages and dendritic cells are key players of inflammation associated with colitis.
1.3.

Monocyte and macrophage recruitment during infection and inflammation:

a role of the chemokines
In this thesis, we have focused on anti-inflammatory role of ribosomal protein
L13a-mediated translational silencing pathway. The expression of several chemokines
and their cognate receptors has been identified to be regulated by this pathway (36).
Therefore, it is essential to have a basic understanding about different classes of
inflammatory monocytes and their mechanisms of recruitment to sites of infection.
Monocytes are a subgroup of circulating leukocytes that can differentiate into a wide
variety of tissue macrophages and dendritic cells (Auffray et al., 2009, Shi and Pamer,
2011). Monocytes have the ability to differentiate in response to signals from
chemokines/cytokines or microbial components and are important mediators of host
microbial defense (Auffray et al., 2009, Serbina et al., 2008). Monocytes and
macrophages have been implicated in a variety of inflammatory diseases including
atherosclerosis (Woollard and Geissmann, 2010), cancer, endotoxemia, IBDs, etc. The
ability of monocytes to be chemo-attracted and recruited to the inflamed tissues is
fundamental to their function in triggering an immune response and driving inflammatory
diseases (Shi and Pamer, 2011).
Monocytes can be categorized into different subsets depending on the expression of
the chemokine receptors and surface molecules. In mice, CD11b and Ly6C positive
monocytes express high levels of the chemokine receptor 2 (CCR2) and are referred to as
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Ly6Chi inflammatory monocytes. These monocytes are present in the peripheral blood
and are immediately recruited to the regions of infection and inflammation (Serbina et al.,
2008). There are a second major class of monocytes which express high levels of
CX3CR1 and low levels of CCR2 and Ly6C (Geissmann et al., 2003). This subset of
monocytes is less frequent in the circulating blood and their main function is to adhere
and migrate along the luminal surface of blood vessels (Auffray et al., 2007). Human
monocytes on the other hand are classified on the basis of (cluster of differentiation)
CD14 or CD16 expression (Ziegler-Heitbrock, 2007). Though the different classes of
monocytes appear to be different in humans and mice, their differentiation and role in
immune defense have been found to be similar (Belge et al., 2002, Ingersoll et al., 2010).
The chemokine ligands and receptors act as important chemo-attractants for recruiting
monocytes and macrophages to sites of tissue infection. CC-chemokine ligand – 2
(CCL2, also known as MCP-1) and CCL7 (also known as MCP-3) are responsible for
binding to CCR2 and henceforth recruitment of the Ly6Chi inflammatory monocytes from
circulation (Tsou et al., 2007). The Ly6ChiCCR2+ monocytes differentiate into classically
activated macrophages (CAMs) and induce inflammation. Unlike the CAMs which are
pro-inflammatory, the alternatively activated macrophages (AAMs) which are induced by
IL-4 and IL-13 are less inflammatory and have secretory and functional capacities
(Gordon, 2003) (Fig. 2). Where the CAMs promote metabolic inflammation and insulin
resistance, the AAMs

aid in damping inflammation and protects from diet-induced

obesity (Odegaard and Chawla, 2011) (Fig. 2). Many types of infections induce the
production of CCL2 resulting in high expression of CCL2 in the serum or within injured
tissues. CCL7 expression is also induced in cases of bacterial infection, which helps in
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trafficking of the Ly6Chi monocytes. Other chemokines such as CCR1 and CCR5 are also
expressed on the surface of many monocytes which bind to the ligands CCL1 (also
known as macrophage inflammatory protein 1 alpha or MIP-1α) and CCL5 and support
chemotaxis (Charo and Ransohoff, 2006). Apart from their roles in refreshing
macrophages and dendritic cells in the steady state, monocytes can be directly recruited
to the inflamed tissues where they carry out anti-microbial activity.
1.4. Resolution of inflammation and its mediators
Accelerated but regulated synthesis of pro-inflammatory cytokines and chemokines by
the macrophages and monocytes is an obligatory attempt by the immune system to
protect the host from invading pathogens. The key to controlling inflammation lies in
understanding and appreciating the mechanisms and molecules which have evolved to
restrict inflammation. This is absolutely necessary for treating inflammatory diseases.
Lipoxins are autocoids that are activated under various conditions and act on both
neutrophils and monocytes. They possess anti-inflammatory functions in the aspect that
they prevent neutrophil infiltration and therefore act as local stop signals (Takano et al.,
1998, Takano et al., 1997). Subsequent studies have also suggested that lipoxins inhibit
peripheral mononuclear (PMN) cell recruitment therefore controls inflammation and
reduces fibrosis (Takano et al., 1998, Takano et al., 1997, Serhan, 2002). Another class of
anti-inflammatory molecules consists of glucocorticoids which stimulate macrophage
phagocytic activity to eliminate apoptotic white blood cells. A third class involves the
resolvins which originate from the precursor polyunsaturated fatty acids (PUFAs) and act
as important mediators to resolve inflammation. Using secreted materials from
inflammatory macrophages and subjecting them to LC-MS/MS techniques, it has been
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shown that resolvins can be biosynthesized from ω-3 fatty acids (Serhan, 2007). They act
by reducing neutrophil infiltration without causing immunosuppression, but at the same
time promoting microbial killing (Spite et al., 2009) and stimulating macrophages to clear
out the apoptotic cells.
1.5. Translation control and regulation of inflammation
Regulation of gene expression at the level of translation can provide essential means
of controlling the briskness of a response and its reversibility (Mazumder et al., 2010).
Regulation of gene expression can be either universal (regulating the global translation of
transcripts) or transcript selective (regulating the expression of a limited group of
messages). The latter case usually involves binding of RNA binding complexes to either
the 3' or 5' untranslated regions (UTRs) of the target messenger RNAs thereby repressing
their translation (Mazumder et al., 2003b, Sonenberg and Hinnebusch, 2009). These
RNA-binding proteins (RBPs) include heterogeneous nuclear ribonucleoproteins
(hmRNP) and other pre-mRNA/mRNA-binding proteins (mRNP) that bind to RNA
through special RNA binding domains (Glisovic et al., 2008). The greater lengths of the
3'-UTRs as compared to the 5'-UTRs makes the former more susceptible to regulation.
Emerging studies suggest that it is mandatory for the immune system to rapidly activate
the synthesis of the inflammatory mediators in response to a pathogenic attack.
Simultaneously, the inflammatory response needs to be attenuated after removal of the
pathogen to promote resolution. Translation control provides a crucial leverage in this
aspect by making use of the pre-existing mRNAs. Since un-regulated synthesis of proinflammatory products can be detrimental for the host leading to neoplastic growth,
endogenous defense mechanisms have evolved to limit inflammation.
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Translational control can regulate the expression of several pro-inflammatory
cytokines. TNF-α is a pro-inflammatory cytokine that is secreted by the lymphocytes,
activated macrophages and mast cells in response to a systemic inflammatory response.
Reports suggest that TNF-α can recruit leukocytes to the sites of inflamed tissue via
activation of cell adhesion molecules (Tsang et al., 2005). Inflammatory genes like TNFα and cyclooxygenase 2 (COX2) contain AU rich elements (AREs) in its 3'-UTR which
can regulate the stability of the parent transcripts by recruiting several protein factors that
bind to them (Mazumder et al., 2010). The presence of these AREs therefore prevent the
overexpression of TNF-α and COX2 and helps in restoring homeostasis. Regulation via
the AREs require the recruitment and subsequent binding of complex RNA binding
proteins which bind to the ARE sequences of the target mRNAs. These ARE binding
proteins (AREBPs) include heterogeneous nuclear ribonucleoprotein (hnRNP)-A1, HuR,
T cell intracellular Ag (TIA)-1, TIA-1–related protein (TIAR) and TTP (Mazumder et al.,
2010). TIA-1 and TIAR have been studied to play important functions in regulating the
expression of not only TNF-α gene (Piecyk et al., 2000, Gueydan et al., 1999) but also
COX2 gene (Dixon et al., 2003). Another inflammatory gene called the matrix
metalloproteinase (MMP)-13 plays important role in remodeling of the extra-cellular
matrix (ECM) and its expression is increased during chronic inflammatory diseases like
cancer. MMP-13 expression has been studied to be silenced by the binding of TIAR (Yu
et al., 2003). Thus the AU rich elements and various other 3'-UTR translation control
mechanisms (which have not been discussed and are beyond the scope of this thesis)
provide efficient regulation of expression of several inflammatory genes thereby
controlling physiological inflammation. In this aspect, I shall discuss in detail one
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recently identified novel mechanism of translational regulation which has possibly
evolved as an endogenous mechanism to limit inflammation. This pathway is called the
Gamma-Interferon Activated Inhibitor of Translation mechanism or the GAIT pathway.
1.5.1. IFN-γ–activated inhibitor of translation pathway: the regulator of IFN-γ–
induced inﬂammation
Recent findings from our laboratory and from a group of other investigators have
identified an IFN-γ induced delayed translational silencing pathway that is active in cells
of myeloid origin (primarily monocytes and macrophages, but also in other lymphocytes)
and regulates the expression of several inflammatory genes (Vyas et al., 2009, Mazumder
and Fox, 1999, Sampath et al., 2003, Mazumder et al., 2003a, Sampath et al., 2004,
Kapasi et al., 2007, Arif et al., 2009, Keene, 2007). In this mechanism, the GAIT
complex, which is a multi-subunit RNA binding complex assembles and binds to the cisacting 29 nucleotide long putative hairpin structure GAIT element present in the 3'-UTR
of its target mRNA (Mazumder and Fox, 1999, Sampath et al., 2003). The GAIT
complex comprises of four protein constituents: ribosomal protein L13a, glutamyl-prolyltRNA synthetase (EPRS), NS1-associated protein 1 (NSAP1) and glyceraldehyde-3
phosphate dehydrogenase (GAPDH) (Fig. 3) (Mazumder et al., 2003a, Sampath et al.,
2004). In this pathway, there occurs phosphorylation dependent release of EPRS from the
amino-acyl tRNA multisynthetase complex during the initial hours of IFN-γ induction
(Sampath et al., 2004, Arif et al., 2009) followed by release of phosphorylated L13a from
the large 60S ribosomal subunit (Mazumder et al., 2003a). The assembly of the GAIT
complex occurs in two distinct steps: in the initial period (within the first 4 hours) of IFNγ induction, EPRS gets phosphorylated and released from the tRNA multi-synthetase
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complex and forms an inactive pre-GAIT complex with NSAP1. In the second step after
another 12 hours, L13a is phosphorylated and released from the 60S subunit and joins
GAPDH and then binds to the pre-GAIT complex to form the functionally active GAIT
complex which then assembles on the GAIT element (Fig. 3). In the course of this
mechanism, phospho-L13a binds to translation initiation factor eIF4G and blocks the
recruitment of the eIF3 bound 40S pre-initiation complex thereby preventing the
formation of the 48S initiation complex and inhibiting translation (Kapasi et al., 2007).

Figure 3. Control of IFN-γ axis and the GAIT model of translational silencing. IL-18 is an
epithelial cell derived factor which induces the production of IFN-γ by the T cells. The synthesis
of both IL-18 and IFN-γ are regulated by specific sequence elements present in the 5'-UTRs of
their prescursor transcripts (left). IFN-γ then induces the activation of the GAIT silencing
pathway in the macrophages (right). The GAIT complex is composed of four different proteins,
L13a, EPRS, NSAP-1 and GAPDH (refer to the text for full names). The silencing pathway is
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initiated by the phosphorylation depended release of EPRS from the aminoacyl tRNA multisynthetase complex followed by release of phosphorylated L13a from the 60S ribosomal subunit.
(the phosphate groups are shown in red). The binding of the functional GAIT complex to the
GAIT element in the 3'-UTRs of the target mRNAs (members of the post-transcriptional operon)
encoding for inflammatory proteins directly silences their expression by blocking the recruitment
of the eIF3 bound 40S pre-initiation complex. Translational silencing of a cohort of inflammatory
proteins by the GAIT complex permits resolution of inflammation. Figure 3 has been adapted
from Figure 4 of “Translation control: a multifaceted regulator of inflammatory response.”
Mazumder, B., Li, X. and Barik, S. 2010. J. Immunol. 184: 3311–3319.

1.5.2. L13a-mediated GAIT pathway acts as a post-transcriptional regulon, of
inflammatory gene expression
Though the concept of operon was believed to exist strictly in the prokaryotic system,
recent studies have implicated the existence of post-transcriptional operons in the
eukaryotic system where a small ensemble of genes performing similar functions can be
regulated by a single mechanism. This mechanism relies on the recognition of specific
structural elements present in the target transcripts by a single RNA-binding complex
(Keene, 2007, Keene and Tenenbaum, 2002). Based on this emerging notion, further
studies from our laboratory, taking a genome-wide approach identified a cohort of
mRNAs encoding proteins having a role in inflammation, to be direct target of the L13adependent GAIT translational silencing pathway (Vyas et al., 2009). Most of these targets
were identified as chemokine ligands and receptors. Chemokines and their cognate
receptors have essential roles in attracting and recruiting immune cells to the sites of
infection, which has been studied to be crucial in the pathogenesis of several
inflammatory diseases. Therefore, regulation of these inflammatory molecules may serve
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as an endogenous defense against pathological outcomes of uncontrolled inflammation.
Many of these target mRNAs were validated independently and were found to contain a
characteristic and functional GAIT element in their 3'-UTRs (Vyas et al., 2009). Our
additional studies also confirmed the absolute requirement of ribosomal protein L13a in
the successful operation of the GAIT silencing pathway but fortunately, depletion of
L13a in monocytic cells did not affect the overall protein synthesis activity of the
ribosome (Chaudhuri et al., 2007).
Based on the foregoing, we had decided to test the consequence of depletion of L13a
in cells of myeloid origin on physiological inflammation. The rationale behind using
myeloid-derived cells was that macrophages and monocytes are the central components
and key effector cells in an immune response. For this purpose, we have generated the
macrophage-specific knockout mice of L13a (designated as L13aflox/floxLysMCre+ mice in
this thesis) and have used this animal model to study uncontrolled inflammation. We
have challenged these knockout animals together with their wild type controls
(designated as L13aflox/flox mice throughout this thesis unless indicated differently) to
different inflammatory assaults like lipopolysaccharide (LPS) and dextran sodium sulfate
(DSS) to induce inflammation and have studied their associated response. The results
discussed in this thesis are direct outcomes of these initiatives taken. This thesis covers
two major studies, the LPS induced endotoxemia model and the DSS-induced
experimental colitis model which have been the two primary projects in the course of my
Ph.D dissertation research. The studies have been discussed in detail in the following two
chapters of this thesis (Chapters II and III respectively).
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CHAPTER II
AN EXTRARIBOSOMAL FUNCTION OF RIBOSOMAL PROTEIN L13A IN
MACROPHAGES RESOLVES INFLAMMATION
2.1. ABSTRACT

Inflammatory response is an imperative role of the immune system to protect the host
against invading pathogens. Synthesis of pro-inflammatory molecules by the immune
cells mediates the inflammatory response. However, uncontrolled inflammation can
prove to be lethal for the host. Although a lot of studies focus on mechanisms that lead to
inflammation, pathways that resolve inflammation are poorly understood. Creating
macrophage-specific knockout mice of ribosomal protein L13a, which relies on the
abrogation of the endogenous translation control of several chemokines and their cognate
receptors, we have tested the physiological consequence of depletion of L13a in resolving
inflammation. Upon challenging with inflammatory assaults like LPS, these animals have
displayed higher susceptibility to LPS-induced endotoxemia, showing poor survival rates,
widespread tissue damage in the lung and liver, infiltration of macrophages and
neutrophils in the major organs (e.g., lungs and kidneys) and in the peritoneum. These
18

knockout animals have also shown elevated levels of several cytokines and chemokines
(e.g., IL-1β, IL-6, MCP-1, MIP-1α, RANTES and KC) in their serum upon LPS
challenge. Macrophages from these knockout animals have shown unregulated synthesis
of several chemokines (e.g., CXCL13, CCL22, CCL8 and CCR3). The macrophages also
failed to show RNA binding GAIT (Gamma-interferon Activated Inhibitor of
Translation) complex formation on the 3'-untranslated regions of the target mRNAs.
Additionally, the macrophages have also shown higher polysomal abundance of these
mRNAs thereby indicating a defect in their translational control. Altogether, these
observations document that the absence of L13a in the macrophages can abrogate the
endogenously imposed translational silencing pathway and cause sustained synthesis of a
group of inflammatory proteins. This unregulated synthesis of pro-inflammatory
molecules could lead to unresolved inflammation and our knockout mice serves as a
novel model to study uncontrolled inflammation in a mammalian host.
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2.2. INTRODUCTION

Inflammation is an adaptive response that is generated by the immune system to toxic
stimuli and conditions such as invasion by foreign pathogens or tissue injury (Majno et
al. 2004, Medzhitov 2008). Thus, inflammatory gene expression and synthesis of proinflammatory molecules play a pivotal role of the immune system to protect the host from
infections. The pro-inflammatory molecules comprises of a variety of inflammatory
mediators such as chemokines, cytokines, vasoactive amines, eicosanoids which are
secreted by the monocytes, macrophages, neutrophils and other key immune cells
(Medzhitov 2008). This initial recognition of infection is crucial in eliciting an immune
response which helps in removal of foreign pathogens and setting up the host’s defense
system (Serbina et al. 2008, Serbina and Pamer 2008). It is generally considered that a
regulated inflammatory response is constructive innate immune response, but unrestricted
synthesis of pro-inflammatory products can have adverse and detrimental effects
(Medzhitov 2010). Thus endogenous mechanisms have evolved to limit the cytokine
storm to permit the resolution of inflammation (Poddar et al. 2013). Although studies
understanding the pathways that contribute to inflammation are well appreciated, those
that have evolved to conclude it remain unclear. Identification and characterization of
such pathways and anti-inflammatory molecules can serve as prime targets for generating
novel therapeutic drugs against inflammation. Our laboratory has identified one such
pathway in a novel animal model which is dependent on the abrogation of L13a mediated
translational silencing mechanism by creating macrophage specific knockout mice of
L13a (L13aflox/floxLysMCre+). The termination of inflammation is markedly jeopardized
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in this new animal model (Poddar et al. 2013). Such uncontrolled inflammation is
coherent with earlier set of studies done in our laboratory discovering a translational
silencing pathway in cells of myeloid origin when induced by interferon-gamma and
requires active participation of ribosomal protein L13a (Mazumder and Fox 1999,
Mazumder et al. 2001, Mazumder et al. 2003, Mazumder and Seshadri 2003, Kapasi et al.
2007, Vyas et al. 2009). To describe the mechanism briefly, when monocytes and
macrophages are treated with interferon-gamma (IFN-γ), after 16 hours of treatment, a
multi-protein complex, known as the GAIT (Gamma Activated Inhibitor of Translation)
complex becomes active and assembles on the GAIT element (a cis-acting element)
present in the 3'-UTR (untranslated region) of target mRNAs and inhibits their
translation. The formation of the GAIT complex requires the phosphorylation dependent
release of ribosomal protein L13a from the 60S large subunit (Mazumder and Sampath et
al. 2003). Further studies from our laboratory also showed that phosphorylated L13a, as a
part of the GAIT complex can bind to translation initiation factor and scaffolding protein,
eIF4G and prevent the recruitment of the eIF3 bound 40S subunit, hence blocking the
formation of the 48S initiation complex and inhibit translation initiation of GAIT element
containing target mRNAs (Kapasi et al. 2007). Our subsequent studies using cell culture
models have also suggested that depletion of L13a in monocytic cells can abrogate the
L13a-dependent translational silencing of its target mRNAs without affecting the total
protein synthesis (Chaudhuri et al. 2007). In addition to our studies, research from other
laboratories has also suggested that production and accumulation of inflammatory
molecules can be regulated by exercising control at their pre-existing mRNA levels
(Mazumder et al. 2010).
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Macrophages and monocytes are key players of an immune response and have a
protective role against various inflammatory assaults, thus help maintaining tissue
homeostasis (Murray et al. 2011). These cells in co-ordination with IFN-γ aid in the
secretion and production of several other chemokines and cytokines which altogether
trigger an innate immune response to kill the invading micro-organisms. Using a
genome-wide screening approach, we have identified that the L13a-dependent GAIT
mediated silencing pathway can act as a post-transcriptional operon and regulate the
synthesis of a cohort of inflammatory genes encoding mostly chemokine ligands and
receptors such as CCL11, CCL22, CCL8, CCL21, CXCL13, CCR3, CCR4 and CCR6
(Vyas et al. 2009). Further detailed studies from our laboratory have also identified
functional GAIT elements in the 3' UTRs of these mRNAs which can recruit the L13a
containing GAIT complex (Vyas et al. 2009). Recent studies indicate that chemokines
and their receptors act as endogenous signals that help to recruit macrophages neutrophils
etc. to the sites of inflammation (Charo and Ransohoff 2006). Based on our previous
observations and available literature in the field we hypothesize that L13a dependent
translational silencing mechanism has evolved as an endogenous defense mechanism to
protect against uncontrolled inflammation. This led us to anticipate that depletion of L13a
in the macrophages could result in sustained synthesis of many inflammatory genes and
thus promote unresolved inflammation due to repudiation of the translational silencing
pathway. To test this at the physiological level, we have generated the macrophagespecific knockout (KO) mice of L13a using the Cre-LoxP system of recombination (Nagy
2000), in which the termination of inflammation is severely compromised. We have
challenged these animals with inflammatory stimuli like lipopolysaccharide (LPS),

22

monitored and studied their response and compared them to those of the similarly treated
controls to get an in-depth understanding of the role played by L13a-mediated
translational silencing pathway in resolving physiological inflammation. The rationale for
using LPS as an inflammatory assault is that LPS triggers production of cytokines by
macrophages, causes systemic inflammation and is also a potent inducer of IFN-γ in cells
of myeloid origin (Le et al. 1986, Mattern et al. 1999, Dai et al. 2008). In this chapter, I
will show and discuss results obtained from the LPS-induced endotoxemia study. In all
the experiments discussed henceforth, we have used the L13aflox/flox mice as experimental
controls and L13aflox/floxLysMCre+ mice as the KOs unless otherwise mentioned (treated
or untreated as will be mentioned specifically for the respective experiments). Upon
challenging the animals with LPS, we have observed higher sensitivity of the KOs to
LPS-induced endotoxemia showing reduced survival rates, severe organ damage, tissue
infiltration of immune cells, infiltration of macrophages and granulocytes in the
peritoneal cavity, overproduction of several chemokines and cytokines and unregulated
expression of several GAIT target proteins which can be attributed to the probable loss of
L13a-mediated translational silencing. In addition, the macrophages harvested from the
LPS treated L13a KO mice have shown greater polysomal abundance of some of the
GAIT target mRNAs and failed RNA binding complex formation on these mRNAs.
Thus, our observations demonstrate a novel extra-ribosomal anti-inflammatory function
of ribosomal protein L13a and our macrophage-specific L13a knockout mice serve as an
innovative animal model to study uncontrolled inflammation in a mammalian host. In this
chapter of the thesis I will present and discuss in detail the observations made and results
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obtained from the LPS-induced endotoxemia study using the KO mice model that
exhibits disruption of L13a-catalyzed translational silencing pathway in the macrophages.
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2.3. MATERIALS AND METHODS

2.3.1. Generation of macrophage-specific L13a knockout mice.
The targeting construct of the L13a gene was designed by introducing LoxP sites
upstream of exon 2 and downstream of exon 8 so that exons 2 to 8 of the L13a gene
could be conditionally targeted. A Neomycin (Neo) cassette flanked by LoxP and FRT
sites was also introduced downstream of exon 8 as a marker for selection of positive
embryonic stem (ES) cell clones. ES cells from C57BL/6 mice were transfected with the
L13a targeting construct. Recombinant ES (rES) clones were selected by genotyping for
the presence of the 1st LoxP site with Lox1/SDL2 primer pair. The primer sequences are
listed in Table 1 of this thesis. Cre-dependent depletion of L13a was confirmed by
infecting the positive ES cell clones with adenovirus expressing Cre recombinase under
the control of the CMV promoter. (Ad-CMV-Cre). Two different rES cell clones were
selected for injection into the blastocytes. The blastocytes were then transferred into a
surrogate mother mouse and the chimeras were generated. The blastocyte injection and
transfer into surrogate mother mouse was done at a contract facility, ingenious Targeting
Laboratory (Ronkonkoma, NY). The chimeras were identified by presence of mixed fur
coat color. The male chimeras were then crossed with wild type (WT) female C57BL/6
mice for germline transmission. The Neo cassette was removed by crossing these animals
with ACTFLP+ mice in the C57BL/6 background (Flipper mice expressing the FLP
transgene under the control of the actin promoter). The F4 generation mice which were
homozygous for the L13a floxed allele (L13aflox/flox) and Neo deletion were confirmed by
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genotyping with Lox1/SDL2 and NDEL3/Anti-AT2 primer pairs. (Primer sequences
listed in Table 1). Lung fibroblasts were isolated from the L13aflox/flox mice and infected
with Ad-CMV-Cre followed by immunoblotting with anti-L13a antibody (Ab), to test for
the Cre-dependent depletion of L13a gene. Finally, the macrophage-specific L13a KO
mice (L13aflox/floxLysMCre+) were generated by crossing the L13aflox/flox mice with
LysMCre+ mice (bought from The Jackson Laboratories, Bar Harbor, ME), where the
expression of the Cre transgene is driven by the Lysogen M promoter which is myeloid
cell-specific. These KOs were identified by genotyping and the macrophage-specific
depletion of L13a gene was confirmed by immunoblotting with anti-L13a Ab.
2.3.2. Animal housing, treatments and induction of endotoxemia.
All animals were housed, and bred according to the rules of National Institute of
Health (NIH) and the Institutional Animal Care and Use Committee (IACUC) of
Cleveland State University. They were supplied with regular drinking water and fed
normal chow diet. For all experiments discussed henceforth, animals aged between 8-12
weeks and of matched genders were used unless otherwise mentioned specifically. All
injections were done intra-peritoneally (i.p.). Peritonitis was induced by i.p. injection of
1.5 ml of 4% thioglycollate solution. Systemic inflammation of endotoxemia was induced
by i.p. injection with LPS (Sigma-Aldrich, St. Louis, MO) at a dose of 15 mg/kg of body
weight. For survival analysis, a sub-lethal dose of 20 mg/kg of body weight was used. For
most experiments except for measuring the serum cytokine levels, LPS injection was
done for 24 hours unless otherwise indicated specifically.
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2.3.3. Isolation of peritoneal macrophages, total leukocytes and peripheral blood
monocytes.
For peritoneal macrophages, mice were injected with either LPS for 24 and 48 hours
or thioglycollate for 48 or 72 hours (as will be mentioned specifically for respective
experiments). After the said time periods, animals were euthanized and peritoneal lavage
was harvested by flushing with ice-cold PBS. Cells were then pelleted and resuspended in
PBS and counted with a cell counter before proceeding with respective experiments.
Total leukocytes were isolated from the spleen by crushing the spleen through a cell
strainer followed by centrifugation and lysis of the red blood cells (RBCs) from the cell
pellet with RBC Lysis Buffer (eBioscience) following the manufacturer’s protocol. The
mononuclear cells were obtained from blood by layering over Ficoll-Hypaque Gradient
followed by centrifugation, using established methods (Kanof et al. 2001).
2.3.4. Flow Cytometry
106 cells per sample were counted and used for staining. Cells were incubated with
rat-anti-mouse CD16/CD32 Fc Block (BD Pharmingen) to block non-specific Fcγ
receptors. Cells were then stained with the following antibodies: FITC (fluorescein
isothiocyanate) conjugated rat-anti-mouse CD11b IgG2b (BD Pharmingen), APC
(allophycocyanin) conjugated rat-anti-mouse F4/80 IgG2b (Abd Serotec), PE
(phycoerythrin) conjugated Ly6G IgG2a (BD Pharmingen), FITC conjugated rat antimouse Mac2 IgG2a (Cedarlane Laboratories) and APC conjugated Ly6C (eBioscience).
Cells were also stained with corresponding isotype control antibodies which included PE
conjugated IgG2b (eBioscience) and FITC conjugated IgG2a (eBioscience), to subtract
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background staining. For peritoneal cells and peripheral blood monocytes, the cells were
gated for leukocytes, for total leukocytes, cells were gated for granulocytes based on their
respective scatters. Flow cytometry analysis was done using the FACSCantoII cytometer
and FACSDiva (BD Biosciences) and FlowJo (TreeStar) softwares.
2.3.5. Quantification of cytokines and chemokines
Serum levels of TNF-α and IFN-γ, and IFN-γ levels secreted by the total leukocytes,
and chemokines secreted by the primary macrophages were measured by ELISA using
commercially available kits (R&D Systems). For detection of chemokines secreted by
macrophages, peritoneal macrophages from each animal were harvested and then plated
(1 x 105 cells /well) in triplicate in RPMI 1640 media supplemented with 10% serum and
antibiotics. Macrophages were selected by overnight adherence. Cells were then washed
with PBS and incubated in fresh RPMI media with or without IFN-γ (500U/mL, from
R&D Systems) for different time intervals. Conditioned media was collected and
subjected to ELISA. Serum levels of IL-1β, MCP-1, KC, RANTES, IL-6 and MIP-1α
were determined using MultiPlex Mouse Quantikine ELISA array in a commercial
facility (Quansys Biosciences, Logan, UT).
2.3.6. Tissue histological analysis
Tissues (lungs and kidneys) were harvested from mice followed by fixation in 10%
neutral buffered formalin (Sigma-Aldrich) for 16 hours and stored in PBS overnight prior
to paraffin embedding and sectioning. For Ym1 staining, tissues were fixed in methanol
(a solution containing 60% methanol, 30% glacial acetic acid and 10% water). 5μM
sections were cut from each block and stained with hematoxylin and eosin (H&E).
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Paraffin embedded tissue sections were deparaffinized and antigen retrieval was done by
incubating with Trilogy solution (Richard Allan Scientific) in a steamer for 30 minutes.
For macrophage staining, rat-anti-mouse anti-Mac2 antibody (Cedarlane Laboratories)
and rat-anti-rabbit anti-Ym1 antibody (Wako Chemicals, USA) were used. Biotin-SP
conjugated appropriate secondary antibodies (Jackson ImmunoResearch) were used.
2.3.7. Polysomal profiling and analysis
Polysomal analysis was done with the lysates made from the peritoneal macrophages
harvested from the control and KO mice injected with LPS (15 mg/kg of body weight)
for 24 hours. Lysates were prepared using 0.5 ml of polysome lysis buffer (10 mM
HEPES, pH 7.5, 100 mM KCl, 2.5 mM MgCl2, 1 mM dithiothreitol, 0.1mg/mL
cycloheximide, 50 U of recombinant RNasin [Promega, Madison, WI] and 0.1% IgepalCA630 [Sigma, St. Louis, MO]. Ten optical density units of the Peritoneal macrophage
extracts from 4 controls and 4 KOs were pooled together and then carefully layered over
5 to 50% linear sucrose gradients prepared in the polysome buffer (as mentioned above
without the RNasin and Igepal-CA630) and centrifuged at 17,000 rpm in a Beckman
SW32.1 Ti rotor for 18 h at 4°C. Gradients were fractionated using an ISCO gradient
fractionation system supplied with a UA-6 detector using an upward displacement
method. Lighter ribonucleoprotein (RNP) fractions, 40S, 60S, 80S, and heavy polysome
fractions were monitored by constant UV absorption profiles at A264, and 12 tubes of 1.2
mL fractions were collected. Total RNA was isolated from each fraction using Trizol
(Invitrogen, CA) and then subjected to reverse transcriptase (RT)-PCR with specific
primers against CXCL13, CCL22, CCR3 and actin. PCR products were then resolved on
1.5% agarose gels.
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2.3.8. Determination of in-vivo interaction of L13a with different chemokine
mRNAs and 60S ribosomal subunit.
The interaction of L13a with cellular mRNAs and the 60S ribosomal subunit was
determined using our previously standardized protocols (Mazumder et al. 2003). Briefly,
macrophage

lysates

containing

500μg

of

total

protein

were

subjected

to

immunoprecipitation reaction using 10μL of affinity purified anti-L13a antibody. The
L13a bound RNA was isolated using Trizol reagent (Invitrogen). For mRNAs, reverse
transcription was done using oligodT primers and random primer was used for the
ribosomal subunit. Specific primer pairs for CCL22, CXCL13 and CCR3 were used.
(detail of primer sequences have been included in Table 1).
2.3.9. Determination of GAIT-element mediated translational silencing activity in
the mouse macrophages.
The translational silencing activity of the mouse macrophages was reconstituted using
a cell-free in-vitro translation system of rabbit reticulocyte lysate. A chimeric luciferase
reporter RNA containing a 29 nucleotide WT GAIT element in its 3'–UTR was generated
using in-vitro transcription with the corresponding DNA construct. 100 ng of the reporter
RNA was used in the in-vitro translation reaction with rabbit reticulocyte lysates
(Promega) in the presence of
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[S] methionine. 4 μg of lysates prepared from peritoneal

macrophages of saline and LPS treated control and KO mice were used to check
translational silencing activity. IFN-γ treated U937 cell lysates for 8 and 24 hours were
used as controls for this experiment. An aliquot of the translation reaction mixture was
resolved by SDS-PAGE (7% polyacrylamide) followed by autoradiography.
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2.3.10. Antibodies for immunoblot analysis
Anti-L13a

antibody

was

previously

raised

against

a

peptide

NVEKKIDKYTEVLKTHG near the C terminus of human L13a gene (Mazumder et al.
2003). This antibody recognizes a specific band both for human and mouse L13a between
28 and 21 kDa. Anti-L28 and anti-actin antibodies were purchased from Santa Cruz
Biotechnology and Sigma-Aldrich, respectively. Anti-Cre recombinase antibody was
bought from Abcam.
2.3.11. Statistical analysis
The log-rank (Mantel-Cox) test was used to determine the differences in the survival
rates between the LPS treated controls and knockouts. All results presented are mean ±
SD. The statistical significance and p values between two groups were calculated using
two-tailed Student’s t test. All statistical analysis were performed using the GraphPad
Prism 5.0 software.
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2.4. RESULTS

2.4.1. Generation of L13aflox/floxLysMCre+ mice which show macrophage-specific
depletion of L13a.
Since macrophages and monocytes are the prime effector cells of inflammatory and
innate immune responses, we have generated the macrophage-specific knockout mice of
L13a using the Cre-Lox system of recombination (Nagy 2000), in order to evaluate the
role of L13a-dependent translational silencing in controlling physiological inflammation.
The design of the targeting construct is shown in Fig. 4A. Lox P sites were inserted in the
targeting construct upstream of exon 2 and downstream of exon 8 of the mouse L13a
genomic sequence. A Neomycin cassette was also introduced into the targeting construct
as a marker flanked by two LoxP, FRT (flippase recognition target) sites to facilitate its
removal. Embryonic stem (ES) cells from C57BL/6 mice were transfected with the L13a
targeting construct and the recombinant embryonic stem (rES) cells harboring the Lox P
allele were identified by PCR genotyping with Lox1/SDL2 primer pair (Fig. 4B). Before
injecting into the blastocytes of surrogate mother mice, the Cre-dependent depletion of
L13a protein in the rES cells was confirmed by infecting with Adenovirus expressing Cre
under the control of the CMV promoter (ad-CMV-Cre, Vector Biolabs, PA) followed by
immunoblotting with anti-L13a antibody (Fig. 4C). The male chimeric mice were
identified by presence of mixed fur coat color (data not shown) and then crossed with
wild type C57Bl/6 female mice for germ line transmission. The neomycin gene from
L13aflox-neo/+ mice was removed by crossing with ACTFLPe+ mice in a C57BL/6
background (The Jackson Laboratory). The F4 mice (L13aflox/flox) homozygous for the
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L13a floxed and Neo deletion allele were confirmed by PCR genotyping with
Lox1/SDL2 and NDEL3/Anti AT2 primer pairs (Fig. 4D). To confirm the Cre-dependent
excision of L13a in the F4 mice, lung fibroblasts were isolated from the the L13a lox/flox
mice followed by infection with Ad-CMV-Cre, followed by immunoblot analysis with
anti-L13a antibody (Fig. 4E). The complete absence of the L13a band in Ad-CMV-Cre
treated L13aflox/flox mice fibroblasts lysates confirmed the successful generation of the F4
mice and its potential to generate the Macrophage-specific L13a KO mice upon future
crossing with appropriate Cre mice.
The macrophage specific knockout mice of L13a (L13aflox/floxLysMCre+) were
generated by crossing L13aflox/flox with LysMCre+ mice (The Jackson Laboratories). In the
LysMCre+ mice, the expression of the Cre transgene is regulated by the Lysogen M
promoter which is active only in cells of myeloid origin. These knockout animals were
confirmed initially by genotyping from DNA isolated from tail snips with Lox1/SDL2
and Cre-specific primers (Fig. 5A). The macrophage specific depletion of L13a was
tested by the immunoblot analysis of lysates obtained from macrophages, liver and
kidneys using anti-L13a antibody. The absence of L13a protein was immunologically
detected in the macrophages; however its expression in the other organs like liver and
kidneys remained unaltered (Fig. 5B). Throughout the study, we have used the
L13aflox/flox mice as our control and the L13aflox/floxLysMCre+ mice as our L13a KO mice
unless otherwise indicated.
The KO mice progeny obtained from crossing of L13aflox/flox mice with LysMCre+
followed normal Mendelian Genetics of distribution with no observed embryonic
lethality. The newborn KO mice were identical to the controls. Under unchallenged
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conditions, no visible symptoms of pathology such as reduced survival, high breath rate,
difference in food or water intake, weight loss, retarded motor activity, growth, fertility
or visible change in major organs was observed in the macrophage-specific L13a KOs.
These observations suggest that depletion of L13a in the macrophages does not cause any
serious defect in animal development.

Figure 4. Generation of F4 mice homozygous for the L13a floxed allele. (A) Design of the
targeting construct. The positions of the LoxP and FRT sites, Neomycin cassette, the long and the
short homology arms are shown. (B) Identification of the mouse recombinant ES cells harboring
the conditional null allele. The recombinant ES cells were genotyped using the Lox1/SDL2
primers and identified on the basis of a doublet band at 263/325 bp. (C) Confirmation of Credependent depletion of L13a protein in the ES cells. The recombinant ES cells were infected with
Ad-CMV-Cre and the Cre dependent depletion was confirmed by immunoblotting with anti-L13a
antibody. (D) Identification of the F4 mice homozygous for the LoxP and Neo deletion allele.
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Tail DNA samples of the F4 generation pups were screened by PCR with the Lox1/SDL2 primer
pair for the LoxP allele and the NDEL2/anti-AT2 primer pair for the Neo deletion allele. The
presence of the 280 bp band shows the deletion of the Neo cassette in both the alleles. The stars
denote two representative animals in a litter which were genotypically confirmed to be
homozygous for LoxP and Neo deletion allele. (E) Fibroblasts were isolated from the lungs of the
F4 mice harboring the conditional null allele and were infected with Ad-CMV-Cre to test the Credependent excision of L13a. This was confirmed by immunoblotting with anti-L13a Ab.

Figure 5. Generation of the macrophage-specific L13a KO mice. (A) The macrophagespecific L13a KO mice were generated by mating L13aflox/flox mice with the L13aflox/+LysMCre+/mice and then genotyping the tail DNA from the progeny with Lox1/SDL2 primer pair for the
LoxP band and Cre-specific primer pairs (The Jackson Laboratories) for the presence of the Cre
transgene. The star denotes one animal from one representative litter which was successfully
genotyped to be homozygous for the LoxP allele (presence of the 325 bp band) and the Cre
transgene (presence of the 700 bp band). This mouse has been designated as the macrophagespecific KO mouse of L13a. (B) Confirmation of the macrophage-specific depletion of L13a.
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Lysates were made from peritoneal macrophages, liver and kidneys harvested from
L13aflox/floxLysMCre+, L13aflox/flox and wild type mice and then subjected to immunoblot analysis
with anti L13a antibody. The blot from the macrophage lysates was reprobed with anti-Actin
antibody.

2.4.2. Macrophage specific L13a KO mice show higher susceptibility to LPS-induced
endotoxin challenge.
Previous studies from our laboratory have shown that L13a-dependent translational
silencing, induced by IFN-γ in monocytes and macrophages can act as a posttranscriptional operon and control the expression of a cohort of inflammatory genes
(Mazumder and Seshadri 2003, Vyas et al. 2009). In our study we have used LPS induced
endotoxemia model to determine the inflammatory response in the knockout animals. The
relevance of this model is based on the ability of LPS to induce IFN-γ in-vivo and
synthesis of pro-inflammatory cytokines by cells of myeloid lineage (Le et al. 1986,
Mattern et al. 1999, Dai et al. 2008). IFN-γ mediated activation of immune cells is
essential in eliciting an inflammatory response. So we hypothesized that if the L13adependent silencing of the cohort of inflammatory gene is absent in the KO animals, they
would be more prone to inflammation and hence LPS-induced pathological outcomes
would be more severe in the knockouts. In order to test this, we treated both control and
L13a KO mice with a sub-lethal dose of LPS (20 mg/kg of body weight) and monitored
their survival over a period of 120 hours post LPS administration. The KO animals
displayed significantly reduced survival rates as compared to the controls (48% versus
78%) (Fig. 6A). A Kaplan-Meier survival curve analysis shows the statistical significance
of the data (Fig.6A). Treatment with LPS is known to cause lethargy and a decrease in

36

the ambulatory activity in mice (Ogimoto et al. 2006, Grossberg et al. 2011). Therefore
we treated our animals with a sub-lethal dose of LPS (15 mg/kg of body weight) and
observed their ambulatory activities up to 25 hours post LPS challenge using a device
equipped to measure the number of brakes in sequential laser beams in two dimensions.
A rapid reduction in the ambulatory activities was observed in the KO group only upon
LPS challenge and not with saline (Fig. 6B). We also measured other parameters of
inflammation like blood urea nitrogen (BUN), aspartate amino-transferase (AST, a liver
enzyme that increases drastically during systemic inflammation) and tumor necrosis
factor-alpha (TNF-α) in the mice serum upon LPS administration and all of them were
found to be significantly elevated in the KO mice (Fig. 6C) Together these results suggest
that macrophage-specific abrogation of L13a in the KO mice leads to increased
sensitivity to endotoxemia.

2.4.3. Macrophage specific depletion of L13a causes increased serum level of
cytokines upon LPS challenge.
Since we had already observed elevated levels of BUN, AST and TNF-α, we decided
to test for other markers of inflammation in the serum of the KO mice. We tested the
serum levels of some other inflammatory cytokines e.g., IL-1β, IL-6, MCP-1, MIP-1α,
RANTES and KC in the LPS treated KO mice and all of them were found to be
significantly elevated in comparison to the control mice (Fig. 7). These results further
document that macrophage-specific depletion of L13a causes increased susceptibility to
endotoxic challenge.
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Figure 6. Macrophage-specific L13a KO animals show enhanced susceptibility to
endotoxemia. (A) Increased mortality of the KO mice in response to endotoxin challenge. Age
and sex matched control, KO and LysMCre+ mice were challenged with a sub-lethal dose of LPS
(20 mg/kg of body weight) and their survivals were monitored over a period of 120 hours. The
survival rates were plotted on a Kaplan-Meier survival curve, n=19 in each group and p=0.042
(log-rank test) (B) Reduced ambulatory activity of the KO mice upon endotoxin challenge. Both
control and KO mice were challenged with LPS (15 mg/kg of body weight) and their motor
activities were monitored for 25 hours post LPS challenge using a device equipped to measure
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brakes in the sequential laser beams in two dimensions. The results are plotted on an arbitrary
scale. Results are mean ± SD (n=8) p=0.0049, unpaired two-tailed Student t test. (C) KO mice
show elevated serum levels of markers of inflammation. Both control and KO animals were
administered with LPS (15 mg/kg of body weight) and their serum levels of BUN, AST and TNFα were measured after 24 hours of LPS challenge. Results are mean ± SD. (n=4), *p= 0.011, **p
= 0.004, ***p = 0.032 paired two-tailed Student t test.

Figure 7. Increased serum levels of inflammatory cytokines in the KO mice upon endotoxin
challenge. Control and KO mice were injected with a sub-lethal dose of LPS (15mg/kg of body
weight) for 12 hours. Blood was then collected through cardiac puncture; serum was isolated and
subjected to a cytokine/chemokine ELISA array in a commercial facility (Quansys Biosciences).
The results are mean ± SD and p values have been calculated using paired two-tailed Student t
test.
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2.4.4. Myeloid specific depletion of L13a causes enhanced macrophage infiltration in
the peritoneum and expansion of leukocyte population in the spleen.

Infiltration of leukocytes in the peritoneal tissue is a characteristic feature of
inflammation and requires signals generated by chemokines and chemokine receptors
(Medzhitov 2010, Shi and Pamer 2011). We reasoned that the macrophage specific
deficiency of L13a in the KO animals could lead to greater influx of leukocytes in the
tissues and peritoneum by removing the endogenous translational silencing of the
chemokines and chemokine receptors. To assess the inflow of mononuclear cell
population in the peritoneum, we employed fluorescence activated cell staining (FACS)
analysis of the peritoneal cells isolated from control and KO mice upon thioglycollate
induced peritonitis and LPS induced endotoxemia. We stained the peritoneal cells with
markers specific for macrophages like CD11b and F4/80 and Gr-1 for granulocytes,. We
then quantified the population of Gr-1/CD11b, F4/80/CD11b and F4/80/Gr-1 double
positive cells upon 24 and 48 hours of LPS and thioglycollate administration to test for
macrophage and neutrophil infiltration. Thioglycollate treatment of KO mice for 48 h
showed significant enhancement of Gr1-CD11b and F4/80-Gr1 double-positive cell
relative to control mice (Fig. 8A). In contrast, since LPS is a far more inflammatory agent
than thioglycollate, LPS treatment for 24 h showed significant enhancement of the double
positive cells in all three categories (Fig. 8B and 8C). No significant differences in the
double positive cells in all three categories were observed with peritoneal cells harvested
from saline injected animals (data not shown). Quantification of the results from four
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different experiments with statistical analysis for saline, thioglycollate and LPS treatment
have been shown in Fig. 8C.

Figure 8. Endotoxin challenge causes increased infiltration of immune cells in the
peritoneum. Control and KO mice were injected with thioglycollate for 48 hours and LPS (15
mg/kg) for 24 hours followed by isolation of their peritoneal lavage. Peritoneal cells were stained
with F4/80, CD11b and Gr-1 antibodies and subjected to flow cytometry analysis. Increased
infiltration of Gr-1/CD11b, F4/80/Gr-1 and F4/80/CD11b double positive cells were found in the
peritoneum of the KO mice upon 48 hours of thioglycollate treatment (A) and 24 hours of LPS
challenge (B). (C) Statistical analysis of the data obtained from 4 animals in each group for
saline, thioglycollate and LPS at 24 and 48 hours post injection are shown. Results are mean ±
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S.D., n=4, the corresponding P values are shown at the top of the bars, calculated using paired
two-tailed Student’s t-test.

Galectin-3, also known as Mac2 is a carbohydrate binding protein expressed on the
surface of highly inflammatory monocytes and macrophages (Dong et al. 1997, Mosser et
al. 2008). To assess the inflammatory macrophage infiltrates we determined the
population of Mac2 positive cells in the peritoneum of LPS treated mice by FACS
analysis. On treatment of our KO mice with LPS for 24 hours, we have found enhanced
infiltration of F4/80/Mac2 and Gr-1/Mac2 double positive cells in the peritoneum,
relative to the control animals (Fig. 9A and B). The quantitative representation of the
results has been included in the right hand side sub-figure C. Negligible populations of
the double positive cells in both controls and knockouts were detected upon saline treated
conditions (data not shown).
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Figure 9. Increased infiltration of inflammatory macrophages in the peritoneum of L13a
KO mice upon endotoxin challenge. Control and KO mice were injected with a sub-lethal dose
of LPS (15mg/kg). 24 hours post injection peritoneal cells were harvested and stained with Mac2,
Gr-1 and F4/80 antibodies. Higher population of F4/80/Mac2 (A) and Gr-1/Mac2 (B) double
positive cells was found in the peritoneum of the KO animals 24 hours post LPS challenge. (C)
Quantifications of the FACS analyzed data are shown on the right hand side panel. Results are
mean ± SD, n=4, the corresponding P values are shown at the top of the bars and calculated using
paired two-tailed Student’s t-test.

Research done in other laboratories in this field has suggested that the spleen can
serve as a reservoir for the leukocytes for their brisk recruitment to the sites of infection
(Swirski et al. 2009). Therefore we measured the population of splenic leukocytes in
response to 48 hours of LPS treatment. In this experiment, spleens were harvested from
LPS challenged animals followed by RBC lysis of the cell suspensions to isolate total
leukocytes. These cells were then stained with F4/80, CD11b and GR-1 antibodies and
subjected to flow cytometry analysis.

Consistent with our expectations, we found

increased population of Gr-1/CD11b, F4/80/CD11b and F4/80/Gr-1 double positive cells
in the KO mice in comparison to the control (Fig. 10A). Quantification of the data has
been shown in fig. 10B. Taken together, these results show that the macrophage specific
depletion of L13a causes higher infiltration of immune cells (macrophages and
neutrophils) in the peritoneum and increased abundance of leukocytes in the spleen in
response to inflammatory stimuli.
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Figure 10. Higher abundance of splenic leukocytes in macrophage-specific L13a KO mice in
response to LPS treatment. Control and KO mice were injected with LPS (15 mg/kg). After 48
hours, animals were euthanized and spleens harvested. Total leukocyte population was isolated
from the splenocytes after RBC lysis. Cells were then stained with F4/80, CD11b and Gr-1
antibodies and subjected to flow cytometry analysis. Higher abundance of F4/80/CD11b, Gr1/CD11b and F4/80/Gr-1 double positive cells were observed in the splenic leukocyte population
of the experimental KO mice. (B) Quantifications of the FACS data. Results are mean ± S.D.,
n=4, the corresponding P values are shown at the top of the bars, P values calculated using paired
two-tailed Student’s t-test.
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2.4.5. Increased abundance of Ly6Ghi/Ly6Chi splenic leukocytes and Ly6Ghi
circulatory monocytes in the KO mice due to absence of L13a dependent silencing
mechanism.
Ly6G is a marker for granulocytes whereas Ly6Chi is a marker for the inflammatory
monocytes. Ly6C+ bone marrow macrophages are released into the peripheral blood from
where they are directly recruited to the sites of inflammation in the tissues. Most of these
inflammatory monocytes then differentiate into macrophages which is important for the
clearance and resolution of inflammation (Gordon and Taylor 2005). We have assessed
the Ly6Chi monocyte population both in the splenic leukocytes as well as in circulation.
The total leukocyte population was harvested from the spleen using same method as
described previously. They were then stained with Ly6G and Ly6C antibodies and
analyzed by flow cytometry. Peripheral blood monocytes were isolated from blood of
LPS treated controls and knockouts using established protocols with Ficoll-Hypaque
gradient centrifugation (Kanof et al. 2001). We have observed Ly6Ghi/Ly6Chi double
positive leukocytes populations in the spleen (Fig 11A) as well as Ly6Chi peripheral
blood monocytes in the circulation (Fig.11B) of the LPS treated KO mice to be
considerably enhanced. Quantitative representations of the data are included on the right
panel of the figure. Therefore, our results suggest that the macrophage specific L13a
deficiency leads to increased recruitment of inflammatory neutrophils and monocytes into
the tissues as well as in circulation to resolve excessive physiological inflammation in the
KO animals.
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Figure 11. Increased abundance of Ly6Ghi/Ly6Chi splenic leukocytes and Ly6Ghi circulatory
monocytes in the KO mice upon endotoxin challenge. Mice were injected with LPS (15mg/kg)
for 24 hours. (A) Total leukocyte population was isolated from the spleen after RBC lysis and the
Ly6Ghi/Ly6Chi percentage of double positive cells were determined by FACS analysis. (B)
Increased abundance of Ly6Chi inflammatory circulating monocytes was observed in circulating
blood of the LPS challenged KO animals. Blood was collected by cardiac puncture followed by
isolation of peripheral blood mono nuclear cells (PBMCs) by Ficoll-Hypaque gradient
centrifugation (C) Upper and lower panels show the statistical representation of the data. Results
are mean ± SD. P values have been calculated using paired two-tailed Student’s t test.
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2.4.6. L13a deficiency in myeloid lineage enhances endotoxemia induced tissue
damage.
One of the essential features of endotoxic shock is severe tissue damage in the organs
in the form of disseminated intravascular coagulation. These injuries are characterized by
widespread blood coagulation and vessel hemorrhage, particularly in the kidney and
lungs (Parillo 1993). Systemic inflammation caused by LPS often translates into the
infiltration of immune cells in the tissues (Puneet et al. 2010, Raetz et al. 2002).
Therefore, we investigated whether macrophage-specific depletion in L13a could cause
greater tissue damage and immune cell infiltrates following LPS administration. Lungs
and kidneys were harvested from 24 hours LPS injected control and knockout mice,
fixed, paraffin embedded, sectioned and stained with H&E, Mac2 and Ym1. Mac2 and
Ym1 are markers for macrophages. Histopathological analysis of the lungs by H&E
staining revealed extensive RBC accumulation in bronchiolar and alveolar spaces in the
KO mice. Whereas, the RBCs were mostly intravascular and confined to the alveolar
walls in the control animals (Fig. 12A). Immunohistochemical staining of the lungs also
showed significantly more Mac2+ macrophages (Fig. 12B, upper panel) lining the blood
vessels in the lung and adherent to vascular endothelium. Fig. 12B lower panel shows
quantitation of the results. These data show greater invasion and adhesion of the
macrophages to the vessel walls of KO mice lungs in response to endotoxemia which is a
hallmark of severe inflammation. Analysis of the kidney sections showed enhanced
infiltration of both Mac2+ (Fig. 12C) and Ym1+ macrophages (Fig. 12D) in the kidney
glomeruli of LPS treated KOs. Statistical representation of the data is shown on the right
of the figures (right panels). In summary, these results demonstrate that absence of L13a
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in the macrophages leads to increased infiltration of these cells in the tissues which is
consistent with the enhanced outcome of LPS induced endotoxic shock in the knockouts.

Figure 12. Infiltration of immune cells in the major organs of KO mice upon LPS challenge.
(A) H&E staining of the bronchus and adjacent alveoli of lung. In the control mice RBCs are
intravascular with more open alveolar spaces, whereas in the KO mice they have penetrated into
the alveolar spaces. (B) Adhesion of macrophages to the blood vessels in the lung. Mac2 staining
for macrophages shows more number of Mac2+ macrophages lining the lung blood vessels of the
L13a KO mice. Quantification of the data is shown on the lower panel. (n=5). (C) and (D).
Infiltration of macrophages in the kidney glomeruli. Kidney sections were stained with anti-Mac2
and anti Ym1 antibodies. In both cases increased presence of Mac2+ and Ym1+ macrophages were
found in the kidney glomeruli of the KO mice. All tissues were fixed in 10% neutral buffered
formalin except for Ym1 where tissues were fixed in methanol (See Materials and Methods
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section). Statistical representation of the results is shown on the right panels. A total of 70 kidney
glomeruli from 6 controls and 6 knockouts were counted for quantitative representation of Mac2
and Ym1 staining results. All results are mean ± SD. P values were calculated using paired twotailed Student’s t test.

2.4.7. Disruption of the L13a mediated silencing pathway in the macrophages results
in unregulated synthesis of the GAIT target proteins in vivo.
To delineate the underlying molecular mechanisms defining the uncontrolled
inflammation in our L13a KO mouse models, we decided to investigate whether the
expression of the target proteins of the L13a-mediated translational silencing mechanism
was up-regulated upon LPS and thioglycollate treatment. For this purpose, animals were
injected with thioglycollate for 72 hours after which peritoneal macrophages were
harvested. Ex-vivo cultures of peritoneal macrophages were then subjected to 0, 8 or 24
hours of IFN-γ (500U/mL) treatment. The conditioned media from these cultures were
subjected to ELISA to check the steady state levels of few GAIT target chemokines,
CCL22, CXCL13 and CCL8. The levels of all three chemokines were found to have
increased significantly at the 24 hour time point in the KOs as compared to the controls
(Fig. 13A). On the contrary, no significant differences in the levels of proteins were
observed after 8 hours of IFN-γ treatment (Fig. 13A). This can be explained on the basis
of activation of the GAIT silencing complex after 24 hours of IFN-γ treatment which
inhibits any further synthesis of the target chemokines in the control mice macrophages,
but not in the knockouts. Bone marrow derived macrophages from control and KO mice
were cultured ex-vivo with or without IFN-γ for 8 and 24 hours respectively and the
culture supernatants were used to determine the levels of CCL22, CXCL13 and CCL8 by
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ELISA. Same results were obtained from the bone marrow derived macrophages with
significant increase in the level of the chemokines after 24 hours of IFN-γ treatment (Fig.
14). In our L13a KO mouse model, LPS is a potent inducer of IFN-γ and proinflammatory cytokines in cells of myeloid lineage (Le et al. 1986, Mattern et al. 1999,
Dai et al. 2008). Therefore, we tested the capability of the macrophages harvested from
LPS treated KO mice to build up a steady state level of the GAIT target proteins.
Consistent with our previous results, we found higher levels of CCL22, CXCL13 and
CCL8 in the conditioned medium of 24 hour ex-vivo culture (Fig. 13B). We then
investigated whether the increase in the steady state levels of the chemokines were due to
increased production of IFN-γ in our KO mouse system. Therefore we determined the
levels of IFN-γ in the serum and the total leukocyte populations obtained from LPS
treated mice. No significant difference was found between the controls and knockouts
upon measuring the levels of IFN-γ produced in the serum and ex-vivo cultures of total
leukocytes harvested at different time points (Fig. 13C). Taken together, these
observations document that the depletion of L13a in the macrophages abrogates the
silencing mechanism imposed on the inflammatory chemokines that leads to their greater
steady state levels in the conditioned medium. This might contribute to enhanced
physiological response to endotoxin challenge.
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Figure 13. Depletion of L13a in the macrophages causes sustained synthesis of chemokine
ligands CCL22, CXCL13 and CCL8. (A) Ex-vivo analysis of peritoneal macrophages from KO
mice showed elevated synthesis of CCL22, CXCL13 and CCL8 upon 24 hours of IFN-γ
treatment (500U/ml). No difference in the protein levels was seen at 8 hours of IFN-γ treatment.
Results are mean ± SD. (n=5/group) *p = 2.5 X 10-5, ** p = 5.2 X 10-6, ***p = 1.6 X 10-6, twotailed Student t test. (B) Peritoneal macrophages harvested from LPS treated KO mice showed
higher accumulated levels of the same chemokine ligands. Steady state levels have been
measured by ELISA from culture supernatants. Results are mean ± SD. (n=5/group) *p = 9.8 X
10-6, **p = 1.9 X 10-4, ***p = 2.7 X 10-6, two-tailed Student t test. (C) Ability to induce IFN-γ
upon LPS administration is similar in both control and KO mice. Serum levels of IFN-γ upon
LPS and saline injection (left panel). Control and KO mice were injected with saline or LPS
(15mg/kg) and their serum levels of IFN-γ was measured by ELISA (n=9). No significant
difference between controls and KOs were observed. Levels of IFN-γ in the total leukocytes
(right panel). Control and KO mice were injected with saline or LPS (15mg/kg). 3 hours post
injection, total leukocytes were isolated after RBC lysis and cultured for various times. IFN-γ was
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measured by ELISA from culture supernatants. No significant difference was observed between
controls and KOs. Results are mean ± SD. (n=5/group).

Figure 14. Ex vivo studies using bone marrow derived macrophages of the KO mice show
high accumulation of chemokine ligands in response to 24 hr of IFN-γ treatment. Mouse
bone marrow cells were differentiated into macrophages by culturing in presence of L929 cell
conditioned media. The bone marrow derived macrophages were treated with IFN-γ (500 U/ml)
for 8 and 24 hours. The chemokine ligands CXCL13, CCL22 and CCL8 were measured by
ELISA from the conditioned medium after different periods of IFN-γ or vehicle treatment.
Results are mean ± s.d, n=4, the corresponding P values were shown at the top of the bar, same P
values were obtained using paired two-tailed Student’s t-test and repeated measures 2 way
ANOVA.

2.4.8. Deficiency of L13a in the macrophages abrogates the translational silencing of
the GAIT target chemokine ligands and receptors.
As a direct mechanistic test of our hypothesis that depletion of L13a in the
macrophages can abrogate the endogenously imposed translational silencing pathway and
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cause increased production of the GAIT target proteins, we determined the polyribosomal
abundance of some of the GAIT target mRNAs in the LPS administered control and KO
mice. Testing the polyribosomal abundance is a widely accepted method to check the
translation efficiencies of mRNAs (Vyas et al. 2009, Brown et al. 2001, Arava et al.
2003). Untranslated messages will co-sediment with the lighter free fractions whereas
actively translated messages will be polyribosome bound and therefore appear with the
heavy polyribosomal fractions. Lysates of peritoneal macrophages isolated from LPS
challenged control and KO mice were subjected to a 5-50% sucrose gradient
centrifugation to separate the translationally active pool of mRNAs from the
translationally inactive one. RNA was isolated from each fraction followed by RT PCR
with specific primers against CCL22, CXCL13 and CCR3, some of the GAIT target
mRNAs. Results showed these mRNAs to be primarily associated with the lighter/free
fractions in the control mice (Fig. 15A left panel), whereas there was a significant shift of
these mRNAs to the heavier polysomal fractions in the KO mice as compared to the
control actin mRNA (Fig. 15A right panel). Translational efficiencies of the target
mRNAs were quantitatively expressed by the ratio of band intensities of the
corresponding mRNAs and actin in polysomal and non-polysomal fractions (Fig. 15B).
This demonstrates that the absence of the L13a mediated silencing pathway in the
macrophages can elevate the translational status of pro-inflammatory chemokines whose
synthesis is very low under normal basal conditions. Similar results were obtained with
bone marrow derived macrophages treated with IFN-γ ex-vivo for 24 hours followed by
polysomal profiling analysis (data not shown).
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Figure 15. L13a is important for the regulation of expression of CCL22, CXCL13 and
CCL8 mRNAs in animal model. (A) Increased polyribosomal abundance of the GAIT target
proteins in the L13a KO mice. Peritoneal macrophages were harvested from control and KO mice
24 hours after LPS treatment (15mg/kg). Lysates were made in polysome lysis buffer (see
Materials and Methods section of this chapter for buffer compositions) and layered on top of a 550% sucrose density gradient and subjected to ultracentrifugation for 18 hours at 17000 rpm at
4⁰C. Total RNA was isolated from each fraction followed by RT-PCR using specific primers
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against CCL22, CXCL13 CCL8 and actin. Significant shift to the heavier polysomal fractions and
increased polysomal abundance in the KO mice was seen only for the GAIT target proteins and
not actin. (B) Quantification of results from (A). Ratios of target mRNA versus actin in
polysomal and non-polysomal fractions were measured by calculating intensities of the
corresponding bands.

To directly test the abrogation of the L13a-dependent translational silencing pathway
in the macrophages from the KO mice we reconstituted the translational silencing exvivo. For this we used a luciferase reporter construct RNA with the authentic GAIT
element from the ceruloplasmin 3'-UTR and cloned in the 3' UTR of the luciferase
reporter, so that its expression is under the regulation of the GAIT pathway mediated
translational control. We have used the T7 gene 10 RNA without the GAIT element as
the control for this reaction. Both of these RNAs were to in-vitro-translation reaction
using cell-free rabbit reticulocyte lysates. Macrophage lysates from saline and LPS
treated control and knockout mice were used to test the translational silencing activity in
mouse macrophages. U937 cell lysates treated with IFN-γ for 8 hours and 24 hours
served as experimental controls. Results from the ex-vivo study showed that treatment
only with LPS (and not saline) can induce the translational silencing activity in the WT
mouse macrophages. However, this silencing activity was found to be absent in the KO
mice macrophages even upon LPS treatment. This result could be due to the absence of
L13a in the macrophages which might abrogate the formation of the functional GAIT
complex (Fig. 16). Translational silencing of the luciferase reporter construct was
observed when lysates from 24 hours of IFN-γ treated U937 cells was used. Together,
this study indicates that macrophage-specific deficiency of L13a can disrupt the
endogenously imposed translational silencing mechanism in-vivo.
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Figure 16. LPS treatment activates the GAIT mediated translational silencing mechanism
in animals. Design of the GAIT element containing reporter luciferase RNA and the control T7
gene 10 RNA are shown in the bottom panel. An authentic GAIT element from the ceruloplasmin
3'-UTR was cloned in the 3'UTR of the luciferase reporter gene. These RNAs were in-vitro
translated in rabbit reticulocyte lysates in the presence or absence of lysates prepared from
macrophages harvested from saline or LPS injected control or KO mice. Lysates from IFN-γ
treated U937 cells for 8 and 24 hours served as positive controls. The translation reaction mixture
was subjected to SDS-PAGE followed by autoradiography to see the translation products.
Translation silencing of the Luciferase gene was seen only in the LPS injected control mouse
macrophages and not in the KO mice macrophages in-spite of LPS treatment.

The ability of the L13a-containing GAIT complex to silence translation of its target
mRNAs relies on its binding to functional GAIT elements in the 3'-UTR (Mazumder et
al. 2003, Vyas et al. 2009). Therefore we investigated the in-vivo interaction of these
target mRNAs with L13a. The chemokines are present at very low undetectable basal
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levels under normal un-induced conditions, but LPS being a potent in-vivo inducer of
IFN-γ can trigger the synthesis of several of the GAIT target chemokines. We have tested
the induction by LPS using peritoneal macrophages from LPS and saline treated WT
mice. RT-PCR analysis of total RNA isolated from the macrophages of LPS and saline
treated mice showed the presence of CCL22 and CCR3 mRNAs only upon LPS treatment
(Fig. 17A). To further test whether L13a indeed associates with these mRNAs in vivo,
macrophages were isolated from LPS treated mice and then subjected to
immunoprecipitation with anti-L13a and control anti-L28 antibody. L28 is another
protein of the large 60S ribosomal subunit and served as a control in this experiment.
RNA was extracted from the immunoprecipitates and subjected to RT-PCR with specific
primers against CCL22 and CCR3. Both the GAIT target mRNAs were only detected in
the immunoprecipitates with anti-L13a antibody and not with the anti-L28
immunoprecipitates (Fig. 17B), thereby confirming that L13a actually binds to the GAIT
target mRNAs in-vivo. Our previous studies using cell culture models have shown the
regulated release of L13a upon IFN-γ treatment (Mazumder et al 2003). Since LPS is a
potent inducer of IFN-γ in-vivo, we determined the association of L13a with the 60S
large ribosomal subunit in the peritoneal macrophages isolated from LPS treated mice.
Lysates of macrophages harvested from saline and LPS treated wild type mice were
immunoprecipitated

with

anti-L13a

antibody

and

RNA

isolated

from

the

immunoprecipitates were subjected to RT-PCR with 28S rRNA specific primers, because
28S is the building block for 60S ribosomal subunit assembly. The results revealed less
association of L13a with the 60S subunit in the macrophages isolated from LPS treated
mice as compared to the saline treated mice (Fig. 17C). Taken together, these results
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demonstrate the in-vivo operation of the L13a-mediated GAIT silencing pathway and that
macrophage specific deficiency of L13a abrogates the naturally imposed silencing
mechanism on the GAIT target mRNAs. This highlights the physiological importance of
this mechanism as an endogenous defense against runaway inflammation.

Figure. 17. in-vivo association of L13a with target mRNAs and release of L13a from the
large ribosomal subunit. (A) RT-PCR of the total RNA isolated from macrophages of LPStreated mice shows induction of CCL22 and CCR3 mRNAs. Macrophages were harvested from
saline or LPS treated mice, total RNA was isolated from them and then subjected to RT-PCR
with specific primers against CCL22 and CCR3. The lower panel shows RT-PCR results with
control actin specific primers (B) Lysates were prepared from macrophages harvested from LPS
injected wild type mice. These lysates were then subjected to immunoprecipitation with anti-L13a
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and control anti-L28 antibodies. RNA was extracted from the immunoprecipitates followed by
RT-PCR with specific primers against CCL22 and CCR3 (upper panel). The efficiency of
immunoprecipitation was confirmed by immunoblot analysis (lower panel) with the respective
antibodies. (C) Reduced association of L13a with the 60S large ribosomal subunit in
macrophages harvested from LPS treated mice. Macrophages harvested from LPS or saline
treated mice were subjected to immunoprecipitation using anti-L13a antibody. An aliquot of the
immunoprecipitates were then subjected to RT-PCR with mouse 28S rRNA-specific primer left
panel). The other aliquot was subjected to immunoblot analysis with anti-L13a antibody (right
panel).
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2.5. DISCUSSION

The elementary discovery of this study is that extra-ribosomal L13a possesses
significant anti-inflammatory role and thus can act as a physiological attenuator of
endotoxin-triggered inflammation. In this study we have used a novel animal model, the
macrophage-specific knockout mice of L13a, to identify the defensive role played by
ribosomal protein L13a-mediated GAIT translational silencing pathway in resolving
uncontrolled inflammation induced by endotoxic shock. Upon targeted abrogation of the
translational silencing pathway by depletion of L13a in the macrophages, the mice
displayed severe symptoms of inflammation in response to endotoxin challenge.
Increased susceptibility was associated with higher mortality rates, reduced activity and
widespread tissue damage in the LPS treated knockouts. The knockouts also showed
reduced motor activity, clinical symptoms of inflammation with high levels of several
markers of inflammation like BUN, AST and TNFα and other cytokines in the serum.
Additionally, infiltration of macrophages in the lungs and kidneys together with intravascular congestion in the lungs was observed in the knockouts upon LPS administration.
The exaggerated inflammatory response seen upon LPS treatment could be attributed to
the overproduction of some of the GAIT target chemokines (e.g., CCL22, CXCL13,
CCR3 and CCL8) in the macrophages harvested from the LPS administered knockout
mice. This is in agreement with our previous observations from in-vitro studies which
suggested that disruption of the L13a mediated GAIT silencing pathway can cause
sustained synthesis of a group of pro-inflammatory proteins by removing the
endogenously imposed regulation. Most fascinatingly, our study also indicates that
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treatment with LPS can induce the L13a mediated translational silencing pathway and
diminish the association of L13a with the 60S ribosomal subunit in the macrophages of
the wild type control animals. In summary, these observations demonstrate that
macrophage specific deficiency of L13a can abrogate the naturally imposed translational
silencing of the GAIT target mRNAs. Thus, our studies have identified the novel
moonlighting function of L13a as an endogenous defense mechanism to resolve runaway
inflammatory response caused by endotoxin challenge.
Past research from our laboratory using in-vitro cell culture models of monocytes had
revealed the capability of ribosomal protein L13a mediated translational silencing
pathway to regulate the expression of a cohort of mRNAs encoding inflammatory
proteins predominantly chemokines and chemokine receptors. Using RNA folding
programs, it was also found that specific segments in the 3'UTRs of the target mRNAs
contained stem loop like structures, conformationally and functionally similar to the
classical GAIT element found in the 3'-UTR of ceruloplasmin mRNA. Subsequent
experiments also showed their role in translational silencing driven by the L13a
containing RNA binding complex (Vyas et al. 2009). These observations are in
agreement with the concept that folding identities between elements present in different
transcripts can lead to translational regulation of multiple transcripts by a single RNA
binding complex, thereby supporting the idea of a post-transcriptional operon in the
eukaryotic system (Morris et al. 2010, Keene 2007). Our experiments using polysomal
analysis of macrophages isolated from LPS treated control and KO mice showed higher
polysomal abundance of a group of mRNAs synthesizing pro-inflammatory chemokines.
To our knowledge this is the first study reporting the importance of a ribosomal-protein
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dependent translational silencing pathway in regulating physiological inflammation. For
the scope of this study, we have just tested the translational regulation on a few target
mRNAs such as CCL22, CXCL13, CCL8 and CCR3, though several other targets
identified from cell culture studies (Vyas et al. 2009) are yet to be tested in our KO mice
model.
Post-transcriptional mechanisms have evolved which regulate the synthesis of
inflammatory proteins at the level of their mRNAs to control inflammation such as
activation and chemo-attraction of T lymphocytes, infiltration of neutrophils, natural
killer cells negotiated cellular toxicity, adhesion of monocytes and macrophages and their
survival in damaged tissues to initiate repair (Mazumder et al. 2010, Anderson 2010).
The pathophysiological importance of these regulatory mechanisms have been
investigated using genetically modified mouse models having impairments in the AUrich sequence of TNF-α 3'UTR (Kontoyiannis et al. 1999) and RNA binding proteins like
TTP (Taylor et al. 1996), TIA-1 (Piecyk et al. 2000) and AUF-1 (Lu et al. 2006). All of
these studies revealed higher inflammatory responses due to overexpression of TNF-α
and associated diseased pathology caused by the altered stability of the TNF-α mRNA
even under unstimulated conditions. However, our macrophage-specific KO mice of
L13a did not show any developmental defects or significant differences from the controls
under unchallenged conditions. Disease pathology was observed in the KOs only upon
LPS administration. It is important to mention here that LPS being an in-vivo inducer of
IFN-γ also activates the L13a dependent translational silencing pathway in mice which in
turn targets LPS-induced messenger RNAs encoding for inflammatory proteins. These
results are consistent with the concept of termination of inflammation by a negative
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feedback response (Nathan and Ding 2010) and distinguishes the L13a dependent
translational silencing from other post-transcriptional mechanisms to regulate
inflammation.
Chemokines and their receptors play a critical function in chemoattracting and
recruiting mononuclear cells to the sites of inflammation in the tissues. This is a
fundamental step in innate immune responses as it aids in tissue repair and clearing out of
the pathogens. But like all biological processes, immune response needs to be controlled
at a certain checkpoint otherwise excessive response might be detrimental for the host.
Our studies show that the deficiency of L13a mediated translational silencing results in
unregulated and overproduction of many chemokines such as CCL22, CXCL13, CCL8
and CCR3. All of these chemokines have important functions in various aspects of
inflammation (e.g., regulating the networking of activated T cells (Chang et al. 1997) and
regulatory T cells (Riezu-Boj et al. 2011) to sites of inflammation by CCL22, the role of
CXCL13 in B cell homing (Gunn et al. 1998) and its connection with early onset of lupus
erythematosus (Proost et al. 1996), activation of a large group of immune cells by CCL8
(Dajani et al.), advancement of LPS induced lung inflammation (Li et al. 2011) and
ulcerative colitis (Manousou et al. 2010) by CCR3. Our results showing elevated levels
of these chemokines in response to endotoxemia are in accordance with the abovementioned previous studies in literature. Another important facet of our study is the
increased abundance of both Mac2+ and Ym1+ macrophages in the kidney glomeruli of
the LPS treated knockouts. Classically activated macrophages express Mac2 whereas
Ym1 expressing macrophages are the alternately activated ones which have prime roles
in wound healing and repair. Therefore connecting our results with the available
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knowledge we can say that a fibrotic response is started at the beginning of acute
inflammation.
In humans, happloinsufficiency of many ribosomal proteins like S19, S17, S7, S15,
L35A, L11 and L36 can lead to serious defects resulting in genetic diseases like
Diamond-Blackfan anemia (Narla and Ebert 2010). In mice, deficiency of L38 leads to
impairment in tissue patterning (Kondrashov et al. 2011). For many other ribosomal
proteins, their deficiencies result in anomalies in ribosome biogenesis (Narla and Ebert
2010). On the contrary, our previous in-vitro studies using human U937 monocytic cells
had shown that depletion of RPL13a does not affect ribosome biogenesis and overall
protein synthesis activity of the ribosome (Chaudhuri et al. 2007). However, according to
our knowledge, the LPS-induced endotoxemia study provides the first evidence of L13a
dependent translational silencing mechanism to simultaneously control the expression of
several inflammatory genes, thereby resolving physiological inflammation caused by
endotoxin challenge. We hypothesize that any abnormality in this pathway may promote
the development of several other inflammatory diseases and targeting this pathway by
small molecules can provide effective means of designing novel therapeutic strategies.
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TABLE I: LIST OF PRIMERS FOR PCR

PRIMER NAME

PRIMER SEQUENCE

Lox1 (F)

5’ AGGTTCTGCTTGAGCATCTGAG 3’

SDL2 (R)

5’ CCGTCAGGATGCCTACTACCCAG 3’

NDEL3 (F)

5’ GGGTGAATCCTTGCTCACGGGAT 3’

Anti AT2 (R)

5’ GCTCTTGTATCTTGGTGCTGACTT 3’

Mouse 28S (X00525)
Forward

5’ GTTGTTGCCATGGTAATCCTGCTCA 3’

Reverse

5’ CAGAAGCAGGTCGTCTACGAATGGT 3’

Mouse-Actin (NM_007393)
Forward

5’ GTCCCTCACCCTCCCAAAAGC 3’

Reverse

5’ AGGTAAGGTGTGCACTTTTAT 3’

Mouse CCL22 (NM_009137)
Forward

5’ TTCTTGCTGTGGCAATTCAGACCT 3’

Reverse

5’ CAGGTCCTCCTCCCTAGGACAGTT 3’

Mouse CXCL13 (NM_018866)
Forward

5’ CTTGTAAAACGCAGGCTTCCACA 3’

Reverse

5’ GGGTCACAGTGCAAAGGAATATA 3’

Mouse CCR3 (NM_009914)
Forward

5’ TTCTACCGGCCCTCACATAC 3’

Reverse

5’ ATCCAGAGAGCACCTCCTGA 3’
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CHAPTER III
EXTRA-RIBOSOMAL L13A PLAYS A CRITICAL ROLE IN PREVENTING
DSS-INDUCED COLITIS
3.1. ABSTRACT

Inflammatory bowel disease (IBD) is a chronic inflammatory disease affecting the
gastro-intestinal mucosa. The exact etiology of IBD is yet to be studied in detail, but both
genetic and environmental factors (commensal microflora, diet etc.) have been shown to
contribute significantly to the pathogenesis of IBD. The intestinal microbiota and
inflammatory cell infiltrates play a predominant role in the pathogenesis of acute colitis.
Recently studies on L13a-mediated GAIT (Gamma–interferon Activated Inhibitor of
Translation) silencing pathway has been implicated as the endogenous defense
mechanism against several inflammatory diseases like endotoxemia and atherosclerosis.
Further dissection into the molecular pathways has revealed that the presence of L13a in
macrophages critical for resolution of inflammation. The goal of our study is to test the
role of L13a-mediated silencing pathway as a physiological defense in dextran sodium
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sulfate (DSS)-induced experimental colitis progression using murine model of
macrophage-specific L13a knockout. The study was initiated by introducing acute colitis
through administration of DSS in drinking water of the animals. Their activities and
disease parameters were monitored and recorded during the course of the study and then
compared to those of similarly treated controls to evaluate the protective role played by
L13a in the macrophages. Upon DSS treatment, the macrophage-specific L13a KO mice
showed more susceptibility to colitis displaying high mortality rates, drastic weight loss,
enhanced rectal bleeding, diarrhea and shortening of colons. Histopathology analysis of
tissue sections from the KO animals has shown erosion of epithelial crypts in the colon
with very high infiltration of macrophages in both the colon and spleen sections.
Additionally, elevated levels of several chemokines and cytokines were found to be
associated with the serum (e.g., MDC, TARC, eotaxin and IL-6) and colon culture
supernatants (IL-1β, IL-6, GM-CSF, eotaxin, KC, MIP-1α and RANTES) of the DSS
administered knockouts, some of which are the previously validated targets of the L13adependent translational silencing pathway. In consistence with this result we have also
found increased polysomal abundance of several GAIT target mRNAs in the colons of
DSS fed knockouts suggesting a defect in translation control of those inflammatory genes
in the colons upon depletion of L13a from the macrophages. These findings suggest that
L13a mediated translational silencing pathway in macrophages contributes significantly
to protect against inflammation and tissue damage in acute colitis.
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3.2. INTRODUCTION

Immune-related disorders including inflammatory bowel diseases (IBD), cancer,
arthritis, etc. have increased in occurrence over the last 50 years. IBD are chronic
inflammatory disorders affecting the gastrointestinal tract along with the colon and small
intestine and are marked by chapters of relapse and remission (Ponder and Long, 2013).
There are two major forms of IBD: Crohn’s Disease (CD) and Ulcerative Colitis (UC).
The pathological features of UC are primarily localized to the colonic mucosa with
localized inflammation and immune cell infiltration whereas CD affects the entire
gastrointestinal tract involving inflammatory lesions and ulcerations (Coskun et al.,
2013). The clinical symptoms of IBD include diarrhea, rectal bleeding, weight loss and
anemia resulting from intestinal inflammation. Over the last few decades the incidence
and prevalence of IBD has been increasing across both pediatric and adult populations.
Presently, the annual occurrence of CD is highest in the United States (20.2 per 100,000,
per person years); whereas the annual occurrence of UC is highest in Europe (24.3 per
100,000 per person years). However, the predominance of both UC and CD are highest in
Europe (505 and 322, per 100,000 per person years respectively) and much lower
elsewhere worldwide (Ponder and Long, 2013).
The human oral-gastrointestinal tract is colonized by trillions of microorganisms,
predominantly bacteria and most of these microorganisms reside in the distal intestine
(Kamada et al., 2013). The variety of bacterial species can vary between individuals and
largely depends on a variety of factors (Gill et al., 2006, Honda and Littman, 2012,
Hayashi et al., 2013). Commensal bacteria constitute the major microbiota environment
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in the gut and contribute to the host physiology in many ways like digestion fermentation
of carbohydrates, nutrient acquisition and protection against invading pathogens
(Kamada et al., 2013, Li et al., 2011). In this mutually beneficial relationship the host
supplies nutrients and niches for the gut microbiota. The host immune responses
generated by the commensal populations helps in determining the distribution and
architecture of the gut microbiota. Thus, a complex interplay between the host immune
system and the commensal bacteria maintains the intestinal homeostasis and the integrity
of the mucosal barrier. Any abnormal interaction between the intestinal mucosal system
and the luminal microbiota may disrupt this barrier and elicit a pro-inflammatory immune
response and cause sustained inflammation leading to IBD. The exact cause of IBD is
unknown but it involves an intricate communication among genetic and environmental
factors that generates an improper mucosal immune response (Coskun et al., 2013, Kaser
et al., 2010, Sartor, 2006). Genetic linkage mapping and genome wide association studies
have revealed several risk granting loci with considerable overlap in genetic risk factors
between CD and UC (Gregersen and Olsson, 2009, Van Limbergen et al., 2009, Cho,
2008, Zhernakova et al., 2009). The intestinal microbiota plays a critical role in
determining the host immune composition under normal physiological conditions and
thus acts as an essential environmental factor in IBD as the target for inflammatory
response (Kaser et al., 2010).
The dextran sodium sulfate (DSS) model has been widely used to induce experimental
colitis in mice, which mimics IBD and then study the contribution of the innate immune
mechanisms in the pathogenesis of colitis (Wirtz et al., 2007). Feeding mice for several
days with DSS supplemented in drinking water induces acute colitis. DSS-induced colitis
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causes a robust inflammatory response characterized by weight loss, liquid diarrhea, high
death rates and marked loss of goblet cells leading to severe epithelial injury. This injury
is characterized by increased permeability of the epithelial cells, disruption of crypt
morphology and infiltration of immune cells in the colons (Wirtz et al., 2007, Ekstrom,
1998). The inflated immune response is generated principally by the invasion of the
lamina propria with innate immune cells (e.g., macrophages, neutrophils, dendritic cells,
natural-killer T cells etc.) which causes an overproduction of pro-inflammatory cytokines
and thereby promoting an inflammatory cascade leading to damage of the intestinal
epithelial cell barrier (Coskun et al., 2013). Macrophages and monocytes are key players
of immune response and have pathogenic and protective roles against various
inflammatory assaults (Murray and Wynn, 2011). Macrophages are one of the most
abundant leukocytes in the intestines of all mammalian species. Mucosal macrophage
numbers in different parts of the intestines appear to correlate to the relative microflora
population (Mowat and Bain, 2011). The intestine is continuously exposed to numerous
antigens and some of them might be potentially harmful. As principle effector cells of the
immune system, macrophages serve a protective role against these agents. Such
protective phagocytic activity can also be directed toward normally harmless antigens
which can potentially disrupt the balance between the intestinal commensal bacteria and
the luminal microbiota thereby leading to IBD (Mowat and Bain, 2011). Thus,
macrophages can be central to the pathogenesis of such diseases.
Previous studies from our laboratory have shown an indispensable role of ribosomal
protein L13a in the translational silencing of a cohort of mRNAs encoding inflammatory
proteins in macrophages. Majority of these target proteins are chemokines and chemokine
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receptors (e.g., CCL1, CCL3, CCL8, CCL11, CCL21, CXCL13, CCL22, CCL25,
CCL27, CCL28, CCR2, CCR3, CCR4, CCR5, CCR6 and CCR7) (Vyas et al., 2009).
This led us to hypothesize that this L13a-dependent translational silencing could function
as an endogenous defense mechanism against diseases caused by uncontrolled
inflammatory response in macrophages. Results from our laboratory also revealed
significant molecular detail about this translational control mechanism. Our work has
identified a multi-subunit RNA binding complex, Interferon-Gamma Activated Inhibitor
of Translation (GAIT) (Sampath et al., 2004) that binds to the 29 nucleotide long GAIT
element present in the 3' untranslated region (UTR) of the target mRNA (Mazumder et
al., 2003a) and silences translation by preventing the formation of 48S initiation complex
(Kapasi et al., 2007). IFN-γ mediated release of phosphorylated L13a from the 60S large
ribosomal subunit has been identified as a critical step for the assembly of the GAIT
complex (Sampath et al., 2003). Together these studies show that L13a dependent
translational silencing is an extra-ribosomal function of this ribosomal protein. Using the
newly generated macrophage-specific knockout mice of L13a we have shown that extraribosomal function of RP-L13a is absolutely essential for resolving inflammation in LPSinduced endotoxemia (Poddar et al., 2013). This part of the study had been discussed in
detail in chapter 2 of this dissertation. Studies using the LPS-induced endotoxemia model
and also high-fat-diet-induced atherosclerosis model (the respective study where I had a
significant contribution, which has been published but has not been included in this
dissertation) (Basu et al., 2014) revealed the critical role of L13a in resolving
physiological inflammation. As aforementioned, the cytokine storm resulting from
infiltration of macrophages and other immune cells into the colon mucosa can cause
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tissue damage and can be important regulators in the pathogenesis of IBD. Therefore we
hypothesize that the presence of L13a in the macrophages can also serve a protective role
against inflammation caused during colitis. To test this hypothesis we took advantage of
our pre-existing model of macrophage-specific L13a knockout mice and subjected them
to DSS containing drinking water in order to induce colitis. During the course of the
disease, we have monitored the different pathological features and symptoms in the
animals to assess inflammation. We have also compared the inflammatory responses in
the knockout animals to those of the respective control mice to better understand the
consequence of the absence of L13a in progression of colitis. In the current chapter we
are going to discuss the methodology and outcomes of this study in detail.
Simultaneously, we have also tried to dissect the molecular mechanism associated with
the anti-inflammatory role of L13a in experimental colitis and other intestinal diseases
like inflammatory bowel diseases (IBDs).
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3.3. MATERIALS AND METHODS

3.3.1. Mice
Macrophage-specific L13a knockout mice (L13aflox/floxLysMCre+) were generated in
the laboratory by crossing L13aflox/flox mice with LysMCre mice, where the expression of
the Cre gene is under the control of the Lysogen M (LysM) promoter which is myeloid
cell specific, in the C57BL/6 background. The details of the conditional KO mice
generation has been outlined in our previously published manuscript (Poddar et al., 2013)
and also in chapter 2 of this dissertation. Macrophage-specific L13a conditional KOs
were harbored, fed and bred in the animal facility of Cleveland State University
following approved IACUC protocols. All animals were specific pathogen-free and were
maintained in pathogen-free conditions and under normal conditions of temperature and
light. The animals were fed normal laboratory chow diet and water as required. All
control mice used for this study are L13aflox/flox and the KOs are L13aflox/floxLysMCre+.
3.3.2. Induction of colitis
Age

and

sex

matched

8-12

weeks

old

control

(L13aflox/flox)

and

KO

(L13aflox/floxLysMCre+) mice were transferred to fresh cages before each respective
experiment and were supplied with 3% DSS (w/v) (molecular weight 36,000-50,000 Da,
MP Biomedicals, OH) continuously for 9 days followed by 1 day of regular drinking
water. For DSS-induced colitis survival study, mice were administered 2.5% DSS water
for 14 days followed by regular drinking water for 7 days. For DSS induced colitis
recovery study the mice were administered 3% DSS water for 7 days to induce colitis
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followed by 4 weeks of regular drinking water for their recovery. For analysis of
cytokines from colon sections, the mice were administered 3% DSS water for 7 days only
followed by 1 day of drinking water. During the course of experiments the mice were
monitored daily for changes in body weights, rectal bleeding and diarrhea to assess the
disease severity. In all experiments, both controls and KOs have received similar
treatments (DSS water in this study) and their differential responses have been measured.
In experiments where normal drinking water data have been included, both controls and
KOs received regular drinking water for same periods of time.
3.3.3. Pathological scoring and assessment of colitis
The hallmarks of colitis like rectal bleeding and diarrhea were monitored in the DSS
administered animals daily during the course of the experiment and were given
appropriate scores on a scale of 0-4. Scoring was done by an individual blinded to the
treatment. For rectal bleeding, scoring was done as follows: 0 = no blood, 2 = prominent
traces of blood and 4 = liquid blood around the anus with 1 and 3 having respective
intermediate scores. The scoring for stool consistency was done as follows: 0 = normal
fecal pellet, 2 = loose fecal pellet and 4 = liquid diarrhea. For measurement of shortening
of colon lengths, colons were harvested from mice after induction of colitis and were
lined along a measuring scale and their lengths determined. Representative colons from
DSS fed control and KOs was photographed. The percentage of epithelial crypt
disruption was assessed by observing each H&E stained colon section under the
microscope by a person blinded to the treatment and recording the percentage of crypt
erosion accordingly, where 0% denotes absolutely normal crypt architecture and 100%
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denotes complete loss of epithelial crypt morphology. A total of 30 colon sections from
10 controls and 10 KOs were assessed.
3.3.4. Tissue histology and immunostaining
For histological analysis, colons and spleens were harvested from DSS administered
animals, fixed in methanol (a mixture of 60% methanol, 30% glacial acetic acid and 10%
water) overnight and paraffin embedded. 5µM sections were cut and the paraffinembedded tissue sections were deparaffinized with Trilogy (Cell Marque, Austin, TX) in
a steamer for 30 min. The colon sections were then stained with H&E, Gomori Trichrome
stain (Richard Allan Scientific, Catalog # 87021) and PAS (Poly Scientific R&D Corp.,
NY, Catalog # cy008) following manufacturer’s protocol. Colon tissues were also stained
for macrophages with purified anti-Mac2 Ab (rat anti-mouse; Cedarlane Laboratories)
followed by incubation with Biotin-SP–conjugated appropriate secondary antibodies
(Jackson ImmunoResearch). The modified H&E staining to view plasma cell and
eosinophil infiltration was done as follows: Colon sections were incubated in xylene
solution (two changes for 10 minutes each) followed by 100%, (two changes for 10
minutes each) 90% and 70% ethanol (1 minute each) followed by rinsing with distilled
water. The sections were then stained with hematoxylin followed by brief rinsing in
water, 0.5% acid alcohol mixture (a mixture of 0.5 ml of hydrochloric acid, 69.8 ml of
isopropanol and 29.7 ml of water) and bluing solution (0.2% ammonia water solution)
and finally stained with 50% Eosin Y solution for 2 minutes. After final dehydration with
ethanol, the colon sections were mounted with mounting medium and viewed under the
microscope.
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3.3.5. Quantification of cytokine and chemokine expression
The cytokine and chemokine profiles were assessed both from the colons and serum of
DSS administered control and knockout animals. After 7 days of DSS water treatment,
the animals were euthanized and their colons were harvested. The distal part of the colons
was used for creating colon lysates for ELISA, whereas the proximal colons were used
for ex-vivo culture. Colon lysates were prepared as follows: colon samples were
transferred to liquid nitrogen for quick freezing followed by chopping of frozen tissues
with razors. 500µL of protease inhibitor (Sigma, Catalog # P2714) was added to the
samples and chopped further in liquid phase. 1 ml of 1.5% triton X-100 (Sigma, Catalog
# T8787-250ML) was added followed by incubation of the tissue samples at 4ºC on a
shaker. Lysates were finally collected by centrifugation at 12000g for 10 minutes. Protein
concentrations were determined and equal amounts of protein were used for ELISA to
determine levels of IL-1β, IL-6, eotaxin, KC, MIP-1α and TARC. The proximal colons
were chopped with sterile razors into minute pieces and were cultured overnight in
DMEM media supplemented with 10% serum and antibiotics in a 37ºC incubator. The
colon culture supernatants were used for ELISA to determine levels of IL-1β, IL-6, GMCSF, IL-10, TNF-α, IFN-γ, eotaxin, KC, MDC, MIP-1α, RANTES and TARC. Blood
was isolated from DSS treated animals by cardiac puncture. Serum was then isolated and
serum levels of IL-6, eotaxin, MDC and TARC were determined by ELISA. The levels of
all cytokines and chemokines were determined using cytokine/chemokine ELISA array in
a commercial facility (Quansys Biosciences, Logan, UT).
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3.3.6. Polysomal fraction analysis
Polysomal analysis was done from colon lysates of control and KO mice fed with DSS
water for 7 days. Colon lysates were prepared by quick freezing of colon tissues in liquid
nitrogen and finely chopping the frozen tissues with a sterile scalpel, followed by
homogenizing the tissue in a Dounce homegenizer in 1 ml of polysome lysis buffer (10
mM HEPES, pH 7.5, 100 mM KCl, 2.5 mM MgCl2, 1 mM dithiothreitol, 0.1mg/mL
cycloheximide, 50U of recombinant RNasin [Promega, WI], 0.1% Igepal-CA630 [Sigma,
St. Louis, MO] and 10mM of sodium orthovanadate [Sigma-Aldrich, MO, USA]).
Twelve optical density units of the colon extracts were carefully layered over 5 to 50%
linear sucrose gradients prepared in the polysome buffer (as mentioned above without the
RNasin, sodium orthovanadate and Igepal-CA630) and centrifuged at 17,000 rpm in a
Beckman SW32.1 Ti rotor for 18 h at 4°C. Gradients were fractionated using an ISCO
gradient fractionation system supplied with a UA-6 detector using an upward
displacement method. Lighter ribonucleoprotein fractions, 40S, 60S, 80S, and heavy
polysome fractions were monitored by constant UV absorption profiles at A254, and 24
tubes of ~750 μL fractions were collected. Total RNA was isolated from each fraction
using Trizol (Invitrogen, CA) and then subjected to reverse transcriptase (RT)-PCR with
specific primers against CXCL13, CCL22, CCR3 and actin. PCR products were resolved
on 1.5% agarose gels. Please refer to Table 1 for details of primer sequences.
3.3.7. Blood agar plating
Blood was isolated from 3% DSS (w/v) water fed animals by cardiac puncture in
tubes containing 0.1M EDTA. Serum was isolated by centrifuging at 4000 rpm for 5
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minutes at room temperature. The serum from each animal was diluted with sterile PBS
in 1:8 ratio and was plated on blood agar plates (Remel Inc., Lenexa, KS). The plates
were incubated at 37⁰C for 24 hours after which colony formation was studied.

3.3.8. Statistical analysis
The log-rank test (Mantel–Cox) was used to determine the statistical significance of
the differences in survival rates between DSS fed controls and knockouts. Results have
been represented as mean ± SD. All other statistical significance of the differences
between groups was determined by a two-tailed Student t test. All statistical analysis was
performed using GraphPad Prism 5.0 software.
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3.4. RESULTS

3.4.1. Macrophage-specific knockout mice of L13a show increased susceptibility to
experimental colitis.
In chapter 2 we have discussed (and also published data in the form of a manuscript)
that macrophage-specific knockout (KO) mice of L13a showed higher susceptibility to
LPS induced endotoxemia due to the depletion of L13a in the macrophages, which also
leads to abrogation of the endogenously imposed silencing mechanism. In the DSSinduced experimental colitis study we have used the same genetically modified murine
models (macrophage-specific L13a KO mice) and have subjected them to an
inflammatory assault in the form of DSS water to assess their physiological response.
Control and knockout mice were subjected to free access to 3% DSS in drinking water
for 9 days followed by 1 day of regular drinking water (Hayashi et al., 2013). The mice
were monitored daily for clinical symptoms of colitis involving weight loss, rectal
bleeding and diarrhea and respective scores were given. The details of the clinical scoring
method have been mentioned in the Materials and Methods section of this chapter. In
comparison to the controls the L13a KO mice showed significant body weight loss
(~10% weight loss in the controls and ~22% weight loss in the KOs) on the 10th day post
DSS treatment (Fig. 18A) together with high clinical scores for rectal bleeding (Fig 18B)
and diarrhea (Fig. 18C), the two major clinical symptoms associated with IBD. No
significant decrease of body weights were observed in mice administered with regular
drinking water for the same time (data not shown) and both groups of animals consumed
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equivalent amounts of food and DSS water over the course of the experiment (data not
shown). On the 10th day, all animals were euthanized; their colons were harvested and
photographed. Shortening of colons, an essential feature associated with colitis was found
to be more evident in the knockouts after 9 days of DSS treatment as shown in Fig. (18D,
left panel). No significant difference in the colon lengths were observed in the regular
drinking water fed animals (Fig. 18D, left panel). Fig. 18D (right panel) shows the
quantitative representation of the data.

Figure 18. Macrophage-specific KO mice of L13a are more susceptible to DSS-induced
colitis. Both groups of control and KO mice were given free access to 3% DSS containing
drinking water for 9 days after which they were supplied with regular drinking water for 1 day.
During the 9 day study, the animals were monitored daily for weight loss, gross rectal bleeding
and stool consistency and relative scores were given. (A) The change in body weights during the
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course of DSS administration is shown. (n = 10 controls and 11 knockouts). (B) The gross rectal
bleeding scores as seen by blood around the anus are plotted. (n=8/group). Scores were given as
follows: 0 – no blood, 1 – slight traces of blood, 2 – prominent traces of blood and 4 – liquid
blood around anus. (C) The feces from the DSS treated mice were given stool consistency scores
as follows: 0 – normal fecal pellet, 2 – loose fecal pellet and 4 – liquid frank diarrhea. (n = 8/
group). (D) On the 10th day, all DSS treated animals were euthanized and their colons were
harvested and photographed. The colons from three control and three KO mice from the DSS
treatment group and one control and one KO animal from the saline treated group have been
shown. The right hand panel shows a quantitative representation of the data. n=4/group for saline
treatment and n=8/ group for DSS treatment. Results are mean ± SD. All p values have been
calculated using paired two-tailed Student t test.

3.4.2. Macrophage-specific L13a knockout mice show reduced survival upon DSS
challenge.

We had observed significant loss of body weights in the knockouts upon DSS
treatment. Loss of body weights was also demonstrated by the controls, but to a much
lower extent. Therefore we wanted to test whether depletion of L13a could translate the
excessive loss of body weights to reduced survival rates in the knockouts. So we supplied
2.5% DSS in drinking water to both groups of control and knockout animals for 15 days
followed by 9 days of regular drinking water. They were monitored for 24 days in total.
In this experiment a lower dose of DSS was used because we were keeping the animals to
the DSS treatment over a longer period of time. According to our expectation, the
knockouts showed much reduced survival rates as compared to the controls (31.25%
survival in the KOs compared to 81.25% survival in the controls) (Fig. 19). This suggests
that presence of L13a in macrophages plays an important role in determining the
susceptibility to colitis and hence survival.
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Figure 19. Macrophage-Specific KO Mice of L13a show reduced survival upon DSS
Treatment. Animals were fed with 2.5% DSS in drinking water for 14 days followed by 7 days
of regular drinking water. They were monitored for 24 days in total for survival. N = 16 in each
group out of which 13 controls (81.25% survival) and only 5 knockouts (31.25% survival) were
found to be alive at the end of the study. P = 0.0049 Log-rank (Mantel-Cox) Test.

3.4.3. Increased inflammation in the colon mucosa in experimentally-induced colitis
upon L13a depletion.
Mounting evidence from the histopathological data in the LPS-induced endotoxemia
study (discussed in chapter 2) (Poddar et al., 2013) suggested that absence of L13a in the
macrophages could lead to greater tissue damage. In case of inflammatory bowel disease,
injury to the colon architecture is a widely accepted phenomenon. Since higher
susceptibility of the mice to colitis upon depletion of L13a was observed, we wanted to
further investigate and assess the symptoms at the tissue level. For this purpose the colon
morphology of the animals at the stage of post DSS administration was studied in detail.
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Colons were harvested from DSS and normal drinking water fed animals, fixed and then
sectioned for histological analysis. Hematoxylin and eosin (H&E) staining of colon tissue
sections obtained from the normal drinking water fed mice (Fig. 20A) did not show any
disease morphology with intact crypt and mucosal architecture and normal distribution of
leukocytes within the lamina propria thereby indicating that under normal untreated
conditions there is no difference between the controls and knockouts. H&E staining
picture from one representative animal in each group is shown. On the contrary, after 9
days of DSS treatment, the knockouts demonstrated striking differences from the
controls. Severe inflammation in the mucosa, muscularis and submucosa with entire loss
of epithelial crypts, and surface epithelia together with immune cell infiltrates (as seen by
the appearance of several tiny purple spots) was found in KO mice colons (Fig. 20B).
Whereas very little to no appreciable disruption of epithelial crypt morphology was seen
in the DSS treated control mice colon sections. A quantitative representation of the H&E
data in terms of percentage of epithelial crypt disruption in each colon sections is shown
(Fig. 20B right panel).
To understand in detail the changes going on at the level of the epithelial crypt
morphology, we have used Periodic acid Schiff (PAS) staining. PAS staining is used to
detect the polysaccharides such as glycogen, glycoproteins and mucin in cells. Goblet
cells or epithelial cells are mucin producing cells and their integrity can be better
understood using PAS staining. This reagent stains the epithelial cells purple to magenta
on a contrasting background and the amount of loss of the magenta implies loss of goblet
cells. Using this stain we have seen only slight perturbation of the crypt architecture in
the DSS treated controls, whereas in the knockouts there was much more erosion of the
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epithelial crypts with high infiltration of the immune cells as seen with H&E (Fig. 20C).
To focus on the changes going on at the muscularis level in the colons, we have used yet
another staining called the Gomori Trichrome Staining (Fig. 20D). This particular stain
stains the muscle and cytoplasmic regions light red to red, normal connective tissue as
light green and collagen as dark green. The nuclei are shown as dark red spots.
Difference in tissue damage between control and KO is evident in this picture, where the
epithelial crypts have completely effaced in the KO colons. There is also more collagen
that has replaced the normal connective tissue in the KO mice colons (more dark green
appearance in the lamina propria and the disrupted crypts). The muscularis also appeared
to be more extended or thickened in some regions of the KO mice colons (Fig. 20E)
thereby showing exaggerated inflammation. Taken together, these observations suggest
that depletion of L13a from the macrophages can lead to greater colon tissue damage in
inflammatory bowel disease.
3.4.4. Depletion of L13a in the macrophages results in greater infiltration of immune
cells in the colon walls in colitis.

Upon induction of systemic inflammation in the L13a KO animals, we had observed
extensive tissue damage with widespread infiltration of macrophages and other immune
cells in various tissues (discussed in chapter 2 of this dissertation). Macrophages are
immune cells primarily concerned with phagocytic removal of pathogens, infected and
apoptotic cells in our body. They are recruited to sites of tissue injury to play a protective
role. Since DSS induced experimental colitis in mice leads to severe injury to the colon
epithelial lining, we have investigated whether the elevated inflammatory response in the
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Figure 20. Enhanced injury to epithelial-crypt morphology in the macrophage-specific L13a
KO mice during colitis. (A) H&E staining of the distal colon sections from normal drinking
water fed mice show no disease morphology. Mice were fed with normal drinking water for 10
days after which they were sacrificed and their colons were harvested, fixed and then stained with
hematoxylin and eosin to study the crypt morphology. Pictures shown at 4X (upper panel) and
20X (lower panel) magnification and on 100 and 10μ scales respectively. N = 3 in each group.
Pictures from one representative animal in each group are shown. (B) H&E stained distal colon
sections from DSS treated mice. Both control and KO mice were fed 3% DSS in drinking water
for 9 days and normal water for 1 day after which they were euthanized, colons were harvested,
fixed and then stained. A total of 9 controls and knockouts were used. Pictures from one
representative mouse colon section from each group are shown at 4X and 20X magnifications on
a 100 μ scale. Statistical representation of the data from DSS fed animals is shown focusing on
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the percentage of colon disruption after DSS treatment. 27 colon sections from 9 mice in each
group have been calculated. (C) PAS staining of DSS treated control and KO mice confirm loss
of epithelial architecture. Colons sections harvested from animals subjected to 9 days of DSS
water treatment were stained with PAS. N=4 in each group. Pictures at 10X magnification from
one representative animal in each group are shown on a 100 μ scale. (D) Gomori Trichrome
staining of colon sections from 3% DSS water fed control and KO mice was done to view the
disruption of the muscularis layer and leukocyte infiltration. N= 4 in each group. Pictures of one
representative animal in each group at 20X magnification are shown.

KOs was also accompanied by increased macrophage infiltrates in the colon mucosa. For
this purpose, colons were harvested from regular drinking water (as vehicle) and 3% DSS
water fed control and KO mice and immunostained with anti-Mac2 antibody to view
infiltration of macrophages in the tissue. Colon sections from vehicle treated mice did not
show any significant presence of immune cells. No disease morphology was observed
with negligible distribution of macrophages just around the crypt region of both control
and KO mice (Fig. 21A). On the contrary the DSS fed KO mice colons showed
conspicuous differences from those of the controls in terms of increased number of Mac2
positive macrophages associated with the crypts, basal membrane and lamina propria.
The lamina propria and the basal muscularis layer in the KO mice colons also appeared to
be more swollen and there was erosion of the normal crypt morphology than those in the
control mice (Fig. 21B). Modified H&E staining of the colons was done to check for
plasma cell and eosinophil invasion. This suggested eosinophil and plasma cell
infiltration in the colon tissues of the DSS fed KOs (Fig. 21C). Based on these results we
can assume that since macrophage infiltration is an immediate response to mucosal injury
that leads to development of acute inflammation, absence of L13a in the macrophages of
the KO mice leads to increased destructive activity of these cells that can result in
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uncontrolled inflammation. Also, since eosinophilia occurs in response to signals from
certain chemokines (e.g., CCL11), therefore, it is possible that accumulation of
eosinophils and plasma cells in the colon tissues harvested from the KO mice could be an
indication of increased disease phenotype due to inability to resolve inflammation.

Figure 21. Infiltration of immune cells in the colon mucosa of the L13a KO mice. (A) Colon
sections from water fed control and KO mice show no significant difference in the presence of
macrophages. Mice were fed with normal drinking water for 10 days after which they were
sacrificed, their colons harvested and stained with Mac2. Pictures from one representative animal
from each group are shown at 20X magnification. (B) Colon sections from DSS water fed KO
mice show greater infiltration of Mac2 positive macrophages in the lamina propria. Colons were
harvested and stained similarly as mentioned above for water fed controls. More number of Mac2
positive macrophages was found in the lamina propria of the KO mice colons. A total of 6
controls and 6 KOs were used. Pictures of colon sections from 2 different mice from each group
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are shown at 20X magnification. (C) DSS treatment leads to infiltration of plasma cells and
eosinophils in the lamina propria and sub-mucosa. Colons harvested from DSS treated mice were
subjected to modified H&E staining to view the plasma cells and eosinophil infiltration. The
plasma cells are indicated with red arrows whereas the eosinophils are indicated with black
arrows. N = 3 in each group. Picture from one representative animal from each group is shown at
60X magnification on a 100μ scale.

3.4.5. Cytokine and chemokine analysis in the colonic tissue of DSS administered
mice.

Infiltration of leukocytes into tissues is a hallmark of inflammation and chemokines
and cytokines can serve as internal cues to attract various immune cells to sites of
inflammation and tissue injury. Our previous observations had confirmed the infiltration
of macrophages, eosinophils and plasma cells in the colons of DSS treated KOs. To gain
further insight into the activation levels of several chemokines and cytokines, we have
performed a chemokine/cytokine ELISA array with both colon culture supernatants as
well as colon tissue homogenates obtained from DSS administered control and KO
animals. The results obtained are shown in Fig. 22. The colon culture supernatants
showed elevated levels of several inflammatory cytokines and chemokines such as, IL1β, IL-6, GM-CSF, IL-10, TNF-α, IFN-γ, eotaxin (CCL11), KC (CXCL1), MDC
(CCL22), MIP-1α (CCL3), RANTES (CCL5) and TARC (CCL17) (Fig. 22A) while the
colon tissue homogenates showed increased levels of IL-1β, IL-6, eotaxin, KC, MIP-1α
and TARC (Fig. 22B). The levels of the abovementioned cytokines and chemokines in
the colons of normal drinking water fed animals were found to be below detection levels
of the assays and hence have been omitted. Together, these results indicate that DSS
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treatment leads to an increased expression of these pro-inflammatory proteins which aid
in recruiting the macrophages to the more inflamed parts of the colons in the KO mice
upon DSS treatment.
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Figure 22. Elevated cytokine and chemokine expression in the colons of DSS treated
knockout mice. Control and knockout mice were given free access to 3% DSS in drinking water
for 7 days after which they were euthanized and their colons harvested. (A) A part of the colon
from each mouse was cultured overnight in DMEM after which the colon culture supernatants
were harvested and then used for ELISA to determine the levels of IL-1β, IL-6, GM-CSF, IL-10,
TNF-α, IFN-γ, eotaxin, KC, MDC, MIP-1α, RANTES and TARC. (B) The other portion of the
colon from each animal was homogenized to obtain tissue lysates. Equal amount of protein
concentrations of total lysates were used for ELISA to determine levels of of IL-1β, IL-6, eotaxin,
KC, MIP-1α and TARC. Lower limit of detection (LLD) of assays are as follows: IL-1β = 2.1
pg/ml, IL-6 = 0.2 pg/ml, IL-10 = 1.9 pg/ml, IFN-γ = 0.3 pg/ml, TNF-α = 1.7 pg/ml, GM-CSF =
0.2 pg/ml, eotaxin = 1.2 pg/ml, KC = 0.4 pg/ml, MDC = 1.1 pg/ml, MIP-1α = 1.4 pg/ml,
RANTES = 0.4 pg/ml and TARC = 3.3 pg/ml. N =5 in each group. Results are mean ± SD. The p
values were determined using the paired two-tailed Student t test.

3.4.6 Disruption of the L13a in the macrophages abrogates the translational
silencing of GAIT target proteins in DSS-induced colitis.
Colon cytokine/chemokine profile analysis showed elevated levels of several
chemokines and cytokines some of which are direct targets of the L13a dependent
translational silencing pathway (eg., eotaxin, MIP1-α, and MDC). To assess whether
there was a direct involvement of the GAIT target proteins in promoting severity of the
disease in DSS-triggered colitis, we determined the translation status of these proteins in
the colons harvested from DSS treated animals. Testing the polyribosomal abundance is a
widely accepted method to check the translation efficiencies of mRNAs (Vyas et al.,
2009, Brown et al., 2001, Arava et al., 2003). Untranslated messages will co-sediment
with the lighter free fractions whereas actively translated messages will be polyribosome
bound and therefore appear with the heavy polyribosomal fractions. Colon lysates were
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prepared from DSS administered control and KO mice and were subjected to a 5-50%
sucrose gradient centrifugation to separate the translationally active and translationally
repressed pools of mRNAs. RNA was isolated from each fraction followed by RT PCR
with specific primers against CCL22, CXCL13 and CCR3, some of the GAIT target
mRNAs. Table 1 contains details of primer sequences. Results showed these mRNAs to
be primarily associated with the lighter/free fractions in the control mice (Fig. 23 left
panel), whereas there was a significant shift of these mRNAs to the heavier polysomal
fractions in the KO mice (Fig. 23 right panel). This result demonstrates that the absence
of the L13a mediated silencing pathway in the macrophages can elevate the translational
status of pro-inflammatory chemokines whose synthesis is very low under normal basal
conditions. Such dysregulation of expression of pro-inflammatory genes can possibly
contribute to increased disease pathology in DSS induced colitis.
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Figure 23. L13a deficiency in macrophages disrupts translational regulation of CCL22,
CXCL13 and CCR3 mRNAs upon DSS treatment. Increased polyribosomal abundance of the
GAIT target proteins in the L13a KO mice. Colons were harvested from control and KO mice
after 7 days of 3% DSS administration. Lysates were made in polysome lysis buffer (see
Materials and Methods section of this chapter for buffer compositions) and layered on top of a 550% sucrose density gradient and subjected to ultracentrifugation for 18 hours at 17000 rpm at
4⁰C. Total RNA was isolated from each fraction followed by RT-PCR using specific primers
against CCL22, CXCL13 CCL8 and actin. Significant shift to the heavier polysomal fractions and
increased polysomal abundance in the KO mice was seen only for the GAIT target proteins and
not actin.

3.4.7. Absence of L13a in macrophages can lead to systemic inflammation resulting
in splenomegaly upon DSS treatment.

Enlargement of the spleen occurs due to systemic inflammatory reaction which also
occurs during DSS-induced acute colitis and can be correlated to the disease severity
(Axelsson et al., 1998, Morteau et al., 2000, Da Silva et al., 2006). Before discussing the
experimental details, we would like to discuss the microscopic anatomy of the spleen in
brief that would help us to better interpret the results discussed in this section. The spleen
has two specific regions – the red pulp and the white pulp. In rodents, the red pulp area is
a site of hematopoiesis in fetal and neonatal animals, whereas innate immune responses
to blood borne antigens are carried out by the white pulp region. The red pulp is made up
of a three dimensional meshwork of the splenic cords (containing the reticular fibers and
associated macrophages) and venous sinuses. The red pulp macrophages are actively
phagocytic and remove old and damages erythrocytes. The white pulp is composed of the
periarteriolar lymphoid sheath (PALS), the follicles and the marginal zone. This region
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contains the lymphocytes, macrophages, dendritic cells, plasma cells, arterioles and the
capillaries. The marginal zone is a unique region of the spleen situated at the interface of
the red pulp and the PALS and follicles.
The LPS-induced endotoxemia study had demonstrated that depletion of L13a in
macrophages leads to enhanced susceptibility to systemic inflammation. Using this
knowledge, we wanted to test whether abrogation of L13a mediated translational
silencing pathway in the macrophages could take the DSS-induced inflammation a step
further to affect the entire system. Since the spleen acts as a reservoir of immune cells,
we have investigated whether deficiency of L13a in the macrophages can also lead to
splenomegaly (enlargement of the spleen) in DSS-induced experimental colitis. Spleens
from DSS fed L13a KO animals were found to be much enlarged, with an increase in
both size and weight as compared to the DSS fed control animals (Fig. 24A). A
quantification of the data has been shown in Fig. 24B. To better understand the
phenomenon that lead to the pronounced enlargement of the spleens only in the
knockouts, we have carried out an immunostaining of the spleen sections with anti-Mac2
antibody. Mac2 staining revealed that there was an increase both in size and number of
macrophages in the white pulp area of the spleen, close to the periarteriolar lymphoid
sheath (PALS) (Fig. 24C). A probable explanation could be that the enlarged
macrophages could be tingible body macrophages which are predominantly found in
germinal centers of secondary lymphoid tissues and contain debris from ingested
lymphocytes phagocytized apoptotic cells. This could indicate that the macrophages in
the white pulp region in the KO mice spleens have become highly activated due to
absence of the silencing pathway in them, thereby phagocytizing more number of injured
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cells and thus increasing in size. These observations can lead us to hypothesize that
absence of the anti-inflammatory function of L13a in the macrophages can exaggerate the
DSS-induced inflammatory response and elevate it to a systemic response whose effects
are visible in the spleen.

Figure 24. Enlargement of spleens and macrophages within the spleen in the macrophagespecific L13a KO mice upon DSS treatment. (A) Increase in spleen size in the DSS treated KO
mice. 3% DSS water fed control and KO mice spleens were harvested and then photographed.
Picture from 3 representative animals from each group has been shown. (B) Quantification of the
difference in spleen size between DSS treated controls and knockouts. N = 10 controls and 9
knockouts. P value was calculated using paired two-tailed Student t test. (C) Increased infiltration
of macrophages with increase in cell size was observed in the KO mice spleens upon DSS
treatment. Spleen sections from DSS treated mice were stained with anti-Mac2 antibody. Increase
in the number of Mac2 positive macrophages together with an increase in their cell size was
observed in the white pulp. Enlarged macrophages are pointed with black arrows. 20X
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magnification picture show the marginal zone including the white and red pulp area of the
spleen). P indicates the periarteriolar lymphoid sheath (PALS) region and F indicates the follicles.
40X magnification picture focus on the white pulp region on a 10 μ scale.

3.4.8. Absence of L13a in the macrophages prevents resolution of inflammation in
DSS-induced colitis.
A series of in-vitro studies performed in our lab to delineate the detailed mechanism
of L13a mediated GAIT silencing pathway identified that this particular pathway is active
during the later time points of interferon gamma (IFN-γ) treatment of myeloid cells,
thereby preventing excess accumulation of inflammatory products and permitting
resolution of inflammation (Mazumder and Fox, 1999, Mazumder et al., 2001, Mazumder
et al., 2003a, Mazumder et al., 2003b, Kapasi et al., 2007, Vyas et al., 2009). Our
hypothesis behind generating the conditional KO mice of L13a was to test the
physiological consequence of uncontrolled inflammation due to the abrogation of the
endogenously imposed translational silencing. To directly test our hypothesis in the
context of the colitis disease model, we have employed the DSS-induced acute colitis
recovery study. In this experiment, we have induced colitis in the mice by feeding them
with DSS water for a short period (7 days) followed regular drinking water over a longer
period of time (4 weeks). In the course of the experiment, we have monitored the changes
in body weights of the controls versus the knockouts and have compared their abilities to
recover from colitis and regain normal activities. The result in terms of percent change in
body weights is shown in Fig. 25. Both controls and KOs showed decrease in their body
weights with induction of colitis till day 11 with more loss seen in the knockouts (22% as
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opposed to 15% in the controls). The experiment was initiated with 8 controls and 8
knockouts. By day 12 of the experiment, only two controls and 5 knockouts were found
to be dead, thereby confirming our previous observations that the L13a KOs are more
susceptible to DSS treatment. The animals were monitored for a period of 35 days in
total and at the end of the study 5 controls and only 2 knockouts were found to have
survived and recovered from the effects of DSS. These were the same animals which had
survived after 12 days and had continued to live till the end of the experiment. Moreover,
the macrophage-specific L13a KOs took a longer time to recover from colitis though
complete recovery in terms of gain in body mass was not observed within the time frame
of the experiment (Fig. 25A). After the span of the experiment (35 days), the survived
animals were euthanized, their colons were harvested, sectioned and stained with PAS for
study the recovery at the tissue level. Epithelial cells lined intestinal crypts were found to
have regenerated to a more extent in the controls than in the knockouts (Fig 25B). Also, a
substantial amount of fibrosis was still evident in the colon sections from the colitis
recovered KOs. These observations suggest that though the knockouts might have shown
a certain degree of recovery in terms of regaining body masses and resuming normal,
regular activities, but at the level of tissue regeneration, recovery was considerably
delayed in comparison to the controls. Taken together these observations demonstrate
that presence of L13a in the macrophages is a critical factor in the execution of the
resolution of inflammation and perhaps plays a protective role against excessive
inflammation in DSS-induced experimental colitis.
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Figure 25. Delayed recovery of L13a KO mice from DSS-induced colitis. (A) Control and
L13a knockout mice were administered 3% DSS in drinking water for 7 days followed by 4
weeks of regular drinking water treatment, allowing them to recover. The animals were
monitored daily for changes in body weights for the entire length of the study for 35 days. At the
end of the study, 5 control mice and only 2 KO mice were found to be alive and have recovered
from colitis from a total of 8 mice in each group with which the study was initiated. The KO mice
showed more loss of body weights and also took more time to regain their normal body masses
and recover from the effects of DSS induced inflammation. (B) PAS staining of colon sections
from Kos show more fibrosis. Colons were harvested from colitis survived control and KO mice
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and sections were subjected to PAS staining. PAS stained colon section pictures from one
representative animal from each group has been shown at 4X (upper panel) and 20X (lower
panel) magnifications respectively. Black arrows indicate regions of fibrosis. Results are mean ±
SD. P value calculated using unpaired two-tailed Student’s t test.

3.4.9.

Macrophage-specific

depletion

of

L13a

amplifies

the

DSS-induced

inflammatory response to septicemia.
In the model of DSS induced colitis the macrophage-specific KO mice of L13a
showed damage in other organs in addition to the hallmark symptoms of colitis. As
discussed earlier we had observed splenomegaly and infiltration of macrophages in the
white pulp region of the spleen, which is normally devoid of them (Fig. 24). Therefore,
we wanted to investigate whether the DSS-induced colonic inflammation could be
amplified to a systemic one. So, we analyzed the serum levels of the pro-inflammatory
cytokines and found significantly elevated levels of IL-6, eotaxin, MDC and TARC in the
serum of the DSS treated knockout mice as compared to the controls (Fig. 26A). Eotaxin
(CCL11) and MDC (CCL22) are direct targets of the L13a mediated GAIT translational
silencing pathway. No cytokines or chemokines were detected in the serum of regular
water fed controls and knockouts (data not shown). Our previous observations from the
endotoxemia study (discussed in Chapter 2) had shown increased expression of a few of
the same GAIT target chemokines upon LPS challenge (Poddar et al., 2013). One of the
pathogenic causes of colitis is imbalance between the commensal microflora and the
intestinal immune response (Kaser et al., 2010, Sartor, 2006). This could potentially lead
to the disruption of the epithelial barrier and the subsequent release of the gut bacteria
into the bloodstream, hence resulting in septic shock or septicemia. To directly test the
presence of live bacteria in the serum samples, we have plated diluted serum samples
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from DSS treated mice on blood agar plates to observe bacterial colony formation. A
total number of 9 controls and 8 knockouts were used for the experiment. Out of 8 KOs,
4 showed formation of multiple colonies whereas only 1 out of the 9 controls showed
significantly less colony formation (Fig. 26B). Pictures from four representative animals
from each group have been shown. Absolutely no colonies were observed from serum of
water fed mice (data not shown). Therefore we hypothesize that the absence of L13a
magnifies the DSS induced inflammatory response to a systemic immune response,
causing increased production of the pro-inflammatory chemokines thereby making the
animals more sensitive to the DSS challenge.
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Figure 26. DSS induced inflammation results in septicemia in the absence of L13a mediated
translation silencing in the macrophages. Mice were administered with 3% DSS supplemented
in drinking water for 9 days after which they were switched to regular drinking water for a day.
On the 10th day, blood was collected through cardiac puncture and serum was isolated from these
animals. (A) The serum samples were analyzed by ELISA to quantify levels of cytokines. The
KO mice serum showed elevated levels of IL-6, MDC, eotaxin and TARC. Results are mean ±
SD. P values were calculated using paired two-tailed Student’s t tests. (B) Serum samples were
diluted with PBS and then plated on blood agar plates. They were incubated at 37⁰C for 24 hours
after which representative plates were photographed. N = 9 controls and 8 KOs. Picture shown
from 4 representative mice in each group.
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3.5. DISCUSSION

In this study, using macrophage-specific knockout mice of L13a, we have examined
the protective anti-inflammatory role of ribosomal protein L13a against DSS induced
experimental colitis (mouse model of IBD). These knockout animals were previously
generated in our laboratory by crossing the L13aflox/flox mice with LysMCre+ mice
(Poddar et al., 2013) and serves as a novel model to study consequences of unregulated
inflammation. In the DSS induced IBD model, colitis was induced by feeding the mice
with 3% DSS containing water. In response, the macrophage-specific L13a knockouts
demonstrated higher susceptibility to colitis and displayed more severe clinical symptoms
of colitis such as reduced survival rates, drastic loss of body weights, high diarrhea and
rectal bleeding and pronounced shortening of colons lengths. In comparison with the
L13aflox/flox control mice, at the microscopic tissue level, the KO mice showed complete
loss of crypt architecture causing disruption of epithelial crypts and surface epithelia and
muscularis layer upon DSS administration. In addition we have found infiltration of
macrophages in the colons of the knockout mice to be significantly higher than the
L13aflox/flox littermates. Assessing the cytokine/chemokine expression profiles in the DSS
treated animals showed much enhanced levels of IL-1β, IL-6, GM-CSF, IL-10, TNF-α,
IFN-γ, eotaxin, KC, MDC, MIP-1α, RANTES and TARC in the colon conditioned media
and IL-1β, IL-6, eotaxin, KC, MIP-1α and TARC in the colon homogenates of the DSS
treated knockouts only. Apart from the colons, DSS induced inflammation was found to
have spread to other organs like the spleen in the macrophage-specific L13a knockout
mice which showed significant enlargement of spleens and infiltration of macrophages in
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the white pulp region of the spleens which are definite signs systemic inflammation. In
addition high serum levels of IL-6, MDC, eotaxin and TARC were observed in the DSS
treated knockouts thereby suggesting that depletion of L13a in the macrophages can lead
to an elevated inflammatory response thereby making the knockout mice more prone to
DSS triggered colitis.
Previous studies from our laboratory had identified ribosomal protein L13a dependent
GAIT-mediated translational silencing pathway to play a critical role in controlling the
expression of several genes encoding inflammatory proteins mainly chemokine ligands
and receptors (Vyas et al., 2009). This, according to our hypothesis acts as a major
pathway in resolving physiological inflammation According to this mechanism, induction
of monocytes and macrophages with IFN-γ leads to the formation of a multi-protein RNA
binding complex known as the GAIT (Gamma-interferon Activated Inhibitor of
Translation) complex which assembles on the cis-acting GAIT element present in the
3'UTR of target mRNAs and inhibits their translation (Mazumder and Fox, 1999,
Mazumder et al., 2001, Mazumder et al., 2003b). This process also requires active
participation of ribosomal protein L13a after its phosphorylation dependent release from
the 60S subunit of the ribosome (Mazumder et al., 2003a, Kapasi et al., 2007). In the
colitis study we have found significant increase in the levels of eotaxin (CCL11) and
MDC (CCL22) both in the colons as well as the serum of the DSS treated KOs. Both of
these chemokines are direct targets of the GAIT-mediated silencing pathway (Vyas et al.,
2009), thereby implicating a possible role of this pathway in controlling DSS induced
colonic inflammation. The colon extracts from DSS fed KOs have also shown increased
polysomal abundance of few GAIT target messages like CCL22, CXCL13 and CCR3

110

(Fig. 6) thus confirming that the deficiency of L13a in the macrophages can disrupt the
endogenous translational silencing of these inflammatory proteins which might contribute
significantly to the inflammation in DSS induced IBD.
It is already known that chemokine receptors and ligands can generate intracellular
signals in response to inflammation to recruit mononuclear cells to sites of infection in
the tissues (Medzhitov, 2010, Shi and Pamer, 2011). MIP-1α (macrophage inflammatory
protein 1 alpha) also known as CCL3 and RANTES, also known as CCL5 are members
of the C-C subfamily of chemokines which are particularly chemotactic for cells of
monocyte linage and lymphocytes (Cook, 1996) and have been reported to have
important roles in inducing inflammation. The expression of MIP-1α can be triggered in
macrophages in response to systemic inflammation by endotoxin (LPS) challenge and in
monocytes by their binding to intracellular cell adhesion molecule I (ICAM-1) (Lukacs et
al., 1994). In our mouse IBD model, we have found enhanced levels of both RANTES
and MIP-1α and increased macrophage infiltrates in the colons of the KOs. RANTES
receptor CCR5 is strongly expressed on macrophages and monocytes (Mueller and
Strange, 2004) and could thus lead to enhanced trafficking of these cells to the colons
thereby promoting colitis in the knockouts. CCR3, the receptor of MIP-1α is a direct
target of the L13a dependent translational silencing pathway and was observed to be
upregulated upon depletion of L13a in the macrophages of the DSS treated knockout
animals. This could have a possible role in increasing expression of its ligand MIP-1α,
which in a positive feedback mechanism leads to greater recruitment of the macrophages
in the colonic mucosa of the DSS treated knockout mice.
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In addition to chemokine expression, IL-1β expression was also found to be increased
in the macrophage-specific L13a knockout mice upon DSS administration. IL-1β is a proinflammatory cytokine and has been demonstrated to play an essential role in intestinal
inflammation associated with colitis and also promoted IBD triggered diarrhea (Elson et
al., 1995, Sartor, 1994). High doses of IL-1β can influence organ damage by inducing
epithelial cell necrosis and obstructing this endogenous activity of IL-1β can alleviate
both acute and chronic IBDs. (Sartor, 1994, Cominelli et al., 1992; Cominelli et al.,
1990). Therefore, the increased expression levels of IL-1β can be correlated to the higher
disease pathogenicity observed in the knockout mice in response to DSS. Significantly
elevated levels of another cytokine, IL-6 was found in the colons and in the serum of the
knockouts upon DSS treatment which can be correlated to enhanced susceptibility of
these animals to colitis. IL-6 is a multi-functional cytokine with implicated roles in
immune responses, cell survival, apoptosis and proliferation (Kishimoto, 2005) and has
also been reported as a significant contributor of DSS induced inflammation in colitis. It
is a NF-κB dependent pro-tumorigenic cytokine which is produced by the lamina propria
myeloid cells and promotes colitis associated cancer (CAC) (Grivennikov et al., 2009).
In the DSS induced experimental colitis model, we have found increased invasion of
the colon mucosa of the DSS treated KOs by the Mac2+ macrophages. Mac2+
macrophages are of the pro-inflammatory nature and could be responsible to inducing
inflammation in the colons in colitis. There are studies which report that a group of
TLR2+ CCR2+ CX3CR1int Ly6Chi GR1+ macrophages induce colonic inflammation by
producing large quantities of TNF-α (Platt et al., 2010). Recent findings also suggest that
the inflammatory cytokines and reactive oxygen species generated in the colon can
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transform the anti-inflammatory macrophages to the pro-inflammatory dendritic cell like
cells which secrete large amounts of IL-12, IL-23 and nitric oxide synthase thereby
promoting colitis (Rivollier et al., 2012). CD14+ macrophages that secrete IL-23 and
TNF-α have been found to be important in promoting Crohn’s disease (Kamada et al.,
2008). Therefore the increased abundance of inflammatory macrophages in the
muscularis, lamina propria and surface epithelia of the DSS treated knockouts could be
causal in the increasing the susceptibility of these mice to colitis.
We have discussed previously that L13a mediated translational silencing pathway can
regulate the expression of several inflammatory chemokines and cytokines, thus playing
an essential role in controlling physiological inflammation. In the previous study using
endotoxemia model, we had demonstrated that genetic depletion of L13a from the
macrophages can result in higher susceptibility to systemic inflammation (Poddar et al.,
2013). In this study we have tested the extra-ribosomal anti-inflammatory function of
L13a dependent translational silencing pathway in the context of DSS induced
experimental colitis. Our results indicate that disruption of the endogenously imposed
translational silencing mechanism in the macrophages influences colitis associated
pathogenesis and also leads to greater infiltration of these cells in the colonic mucosa.
Colonic infiltration of immune cells and disruption of the crypt morphology in the
intestinal epithelial cells are important contributors of inflammatory bowel diseases. In
the present colitis study, we have experimentally confirmed the increased translational
status of some GAIT target mRNAs (e.g., CCL22, CXCL13 and CCR3) in the colons of
the DSS treated knockout animals by testing their polysomal abundance. This mechanism
could potentially contribute to the increased susceptibility of our knockout mice to colitis.
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Till date, GAIT silencing pathway has been studied to operate only in cells of myeloid
origin but our results show similar translational regulation of inflammatory genes in the
colons upon induction with DSS. Whether DSS triggers synthesis of IFN-γ in-vivo, is an
aspect which still needs further exploration. At this point, we are exactly not certain
about the mechanism via which the L13a dependent GAIT silencing pathway operates to
provide protection against colitis, but our observations indicate a definitive role of several
of the GAIT target molecules in increasing the severity of colitis. Additionally, our
results also suggest that the absence of this endogenous pathway can exaggerate the
colitic response to spread to the entire system leading to septicemia. Taken together, we
can say that L13a mediated translational silencing pathway could have evolved as an
endogenous defense mechanism to protect against inflammation triggered by various
inflammatory stimuli. Modulating specific targets in this pathway can serve as novel
means to design future therapeutic strategies against acute and chronic inflammatory
diseases.
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CHAPTER IV
DISCUSSION

Inflammation is an obligatory response of the host immune system to protect from
invasion by foreign pathogens. Therefore it is critical for the immune cells to synthesize a
variety of pro-inflammatory molecules (including chemokines, cytokines, reactive
amines, eicosanoids, reactive oxygen and nitrogen species) to mediate the inflammatory
response and clear out the pathogens. Where a controlled and regulated inflammatory
response is appreciated and beneficial for the host, an unregulated inflammatory response
can result in an autoimmune attack thereby proving to be detrimental for the host itself.
Macrophage mediated inflammatory response has been implicated in the pathogenesis of
several inflammatory diseases like atherosclerosis (Tabas, 2010), Alzheimers, multiple
sclerosis (Amor et al., 2010), cancer (Sica et al., 2008), arthritis (Kelly and Ramanan,
2007), endotoxemia (Poddar et al., 2013) and inflammatory bowel diseases (Heinsbroek
and Gordon, 2009). It is essential to restrict the uncontrolled synthesis of inflammatory
molecules by the immune cells to resolve inflammation. Thus we hypothesize that
endogenous defense mechanisms have evolved as crucial checkpoints of inflammation
and restore homeostasis. Recent findings from our laboratory had identified one such
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mechanism called the Gamma-Interferon Activated Inhibitor of Translation (GAIT)
pathway involving active participation of ribosomal protein L13a. In this thesis, we have
discussed study where we have tested the importance of the L13a catalyzed GAIT
silencing pathway in resolving physiological inflammation. We have used the recently
generated macrophage-specific knockout mice model of ribosomal protein L13a (62) to
investigate the physiological consequence of abrogating the endogenously imposed
silencing mechanism in the macrophages. Our hypothesis behind this experimental
design was that depletion of L13a in the macrophages would disrupt the translational
silencing of several inflammatory genes (which have been identified as direct targets of
the GAIT silencing pathway) resulting in unresolved inflammation in response to
inflammatory stimuli. We have used LPS mediated endotoxin challenge and DSS induced
experimental colitis as two different inflammatory assaults to investigate the role of L13a
dependent translational silencing pathway in providing protection against systemic
inflammation (Poddar et al., 2013, and also outlined in detail in chapter 2 of this thesis)
and experimental colitis (described in chapter 3 of this thesis).
Our studies using the LPS-induced endotoxemia model and DSS induced
experimental colitis have revealed the essential extra-ribosomal role of L13a in the
macrophages as an endogenous defense against endotoxin induced systemic
inflammation (Poddar et al., 2013) and DSS induced colitis (manuscript under
preparation). Since the latter mimics inflammatory bowel diseases in humans, therefore
the protective role of L13a in the macrophages can be extended to include various types
of IBDs like Crohn’s disease and Ulcerative Colitis (UC). LPS is a potent in-vivo inducer
of IFN-γ in cells of myeloid origin (Le et al., 1986) and thus can induce IFN-γ stimulated
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L13a catalyzed GAIT silencing pathway in the mouse macrophages. Upon treatment with
sub-lethal dose of LPS, the macrophage-specific knockout mice of L13a displayed higher
susceptibility to endotoxemia showing reduced survival rates, retarded motor activity and
high levels of serum TNF-α, BUN and AST (Fig. 6 of chapter 2), common inflammatory
markers whose expression is elevated in LPS induced systemic shock (Lu et al., 2006). In
the DSS study, treatment of animals with 3% DSS for a week led to enhanced sensitivity
of the knockouts to colitis. The DSS administered knockouts displayed clinical symptoms
of colitis such as shortening of colons, reduced survival, loss of body weights, higher
pathology scores to a greater extent than the DSS treated controls (Figures 18 and 19 of
chapter 3). Assessment of colons from the DSS treated animals also showed severe injury
to the colon epithelial crypt architecture in the knockout mice. The DSS fed controls also
showed some loss of surface epithelia, but to a far lesser extent than the knockouts
(Figure 20 of chapter 3). These data suggest that the depletion of L13a in the
macrophages increases the severity of inflammatory response in DSS induced colitis just
the same as LPS induced systemic inflammation.
Studies over the past few decades have focused on the importance of cytokine and
chemokine cascades in acting as endogenous cues to attract and recruit immune cells to
sites of inflammation (Shi and Pamer, 2011, Medzhitov, 2010). Chemokines like MIP-1α
(macrophage inflammatory protein 1 alpha) and RANTES can act as major
chemoattractants for various lymphocytes and cells of myeloid lineage (Cook, 1996) and
MIP-1α expression can also be triggered in macrophages in response to LPS challenge
(Lukacs et al., 1994). Cytokines like IL-1β has been demonstrated to have essential roles
on mediating endotoxic shock response (Lu et al., 2006) and intestinal inflammation
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promoting IBD induced diarrhea (Sartor, 1994). IL-6 is a multi-functional cytokine with
implicated roles in inflammatory response, cell proliferation, apoptosis and DSS induced
colonic inflammation (Kishimoto, 2005). All of these abovementioned chemokines and
cytokines (MIP-1α, RANTES, IL-1 and IL-1β) were found to be elevated in the serum of
the LPS treated knockouts and in the colons of the DSS administered macrophagespecific L13a knockout mice (Figure 7 of chapter 2 and figure 23 of chapter 3). Our
results also indicated the increased level of IL-6 in the serum of the DSS treated KOs
(Figure 26 of chapter 3). Our data thereby suggest that the production of several
cytokines and chemokines which are not direct targets of the GAIT silencing pathway
can be increased upon depleting L13a from the macrophages. Although this might not be
a direct consequence of L13a deficiency in the macrophages and just a downstream
outcome, nevertheless, the increased levels of these cytokines may contribute toward
increasing the severity of inflammation. Such actions could potentially contribute
towards the pathogenesis of colitis and septic shock.
Infiltration of leukocytes in the peritoneal tissue is a characteristic trait of
inflammation and occurs in response to signals generated by chemokines and cytokines
(Shi and Pamer, 2011, Medzhitov, 2010).

Injection with LPS showed increased

infiltration of macrophages and granulocytes in the peritoneum of the KOs (Figures 8 and
9 of chapter 2). A population of these macrophages were found to be Mac2 positive thus
suggesting their pro-inflammatory nature. Spleen acts as a reservoir of immune cells and
initiates their precise recruitment to the inflamed tissues upon tissue injury following a
microbial attack (Swirski et al., 2009). Our results have shown higher population of
CD11b/F4/80, Gr-1/F4/80 and CD11b/Gr-1 double positive macrophages in the splenic
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leukocyte population also (Figure 10 of chapter 2). Further analysis has suggested the
increase in population of Ly6Chi inflammatory monocytes in the peripheral blood of the
LPS treated knockouts (Figure 11 of chapter 2). The Ly6Chi monocytes are immediately
recruited to the sites of infection where they differentiate into the classically activated
macrophages (CAMs) and induce inflammation (Shi and Pamer, 2011). This implies that
disruption of endogenous translational silencing of the inflammatory genes leads to their
sustained synthesis which triggers greater migration and abundance of the proinflammatory leukocytes in the peripheral tissues. These results are further supported by
our additional experiments which have shown extensive tissue damage. The macrophagespecific L13a knockout mice have shown intravascular congestion and infiltration of
Mac2 positive macrophages in the lungs and increased infiltration of both Mac2 and Ym1
positive macrophages in the kidney glomeruli upon LPS challenge (Figure 12 of chapter
2). Ym1 expressing macrophages are primarily involved in wound healing (Mosser and
Edwards, 2008) and there can be switching between pro and anti-inflammatory
macrophages depending of the severity of inflammation. When the generated
inflammatory response peaks, then the Ym1+ macrophages rush there to initiate a fibrotic
response and facilitate wound repair. Greater invasion of the colon mucosa by
inflammatory macrophages were also evident in the DSS administered knockout mice
(Figure 21 of chapter 3) as ascertained with Mac2 staining. Infiltration of the colon
mucosa with leukocytes is a hallmark of colonic inflammation and contributes toward the
pathogenesis of IBDs. Taken together our results demonstrate that disruption of the GAIT
silencing pathway by knocking out L13a in the macrophages is like deactivation of a
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critical checkpoint of inflammation which contributes to the severity of disease
progression.
Previous studies from our laboratory using in-vitro cell culture models had identified a
cluster of genes encoding for chemokines and chemokine receptors under the
translational regulation of the GAIT pathway (Vyas et al., 2009). Further analysis had
identified the characteristic GAIT element in the 3'-UTRs of these mRNA encoding
inflammatory proteins. Our subsequent studies also revealed that the regulation of this
cohort of target mRNAs is mediated through the binding of L13a-dependent RNA
binding complex to the GAIT element harbored in the 3'-UTR (Vyas et al., 2009). Our
findings using the macrophage-specific knockout murine model for LPS induced
endotoxemia and DSS-induced colitis showed increased synthesis and increased
translational efficiencies of several of the GAIT target chemokines (Figures 13 and 15 of
chapter 2 and Figure 23 of chapter 3). Our experimental findings using lysates made from
the macrophages of LPS injected animals and lysates made from the colons of DSS
administered mice in in-vitro-translation assays (data not shown) also confirm that the
sustained synthesis of the GAIT target inflammatory proteins is due to abrogation of the
translational silencing mechanism due to genetic deficiency of L13a in the macrophages
(Figure 16 of chapter 2 and data not shown). These results altogether demonstrate that
depletion of L13a in the macrophages abrogate the endogenously imposed translation
regulation of several inflammatory genes thereby leading to their continued production.
This could possibly cause the severity of inflammation and higher susceptibility of the
macrophage-specific L13a knockouts to LPS-induced septic shock and DSS-induced
colitis.
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Post-transcriptional control of many genes implicated in inflammation has been
reported and is a subject of interest in the context of our research. These genes are
involved in several cellular events connected to inflammation such as activation and
recruitment of T cells, incursion of neutrophils, natural killer (NK) cells mediated cellular
toxicity, adherence of monocytes and survival of macrophages in damaged tissues
(Mazumder et al., 2010, Anderson, 2010). The pathophysiological significance of such
regulatory mechanisms have been studied using genetically modified murine models of
the TNF-α gene with genetically impaired or deleted AU-rich sequences (AREs)
(Kontoyiannis et al., 1999). The AREs present in the 3'-UTRs of several inflammatory
mRNAs regulate their stability by recruiting certain RNA binding complexes and hence
regulating their translation. Such RNA binding proteins which can modulate the
expression of TNF-α have been studied to be TTP (Taylor et al., 1996), TIA-1 (Piecyk et
al., 2000) and AUF-1 (Lu et al., 2006). All of these studies have shown overexpression of
TNF-α due to the loss of the AU-rich elements and those mice have displayed increased
disease pathology even under unchallenged conditions. However, in our study, no such
significant differences were observed between the knockouts and their wild type
littermate controls under normal unchallenged conditions.
Macrophages have been studied to be crucial in the pathogenesis of several
inflammatory diseases including atherosclerosis (Tabas, 2010). However, the endogenous
defense mechanism which have evolved to protect against atherosclerosis have been
poorly appreciated. Very recently published studies from our laboratory have identified
the L13a-catalyzed GAIT translational silencing mechanism in acting as an endogenous
defense mechanism against atherosclerosis (Basu et al., 2014). (This was one of my
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secondary projects in the course of my Ph.D. research, where I had active participation
and I am also the second author in the published manuscript resulting from this study). As
our studies using the LPS-induced endotoxemia model had suggested that presence of
L13a in the macrophages can act as a physiological attenuator of inflammation, therefore
we hypothesized that the same pathway could offer protection against uncontrolled
inflammation in atherosclerosis. To test our hypothesis, we used the same genetically
engineered murine models of L13a, i.e., the macrophage-specific knockout mice of L13a
and crossed them with mice in the ApoE-/- background to generate macrophage-specific
KO mice of L13a in the ApoE knockout background. We induced atherosclerosis in
these animals by subjecting them to prolonged feeding of high-fat diet, our rationale
being that absence of L13a would increase the susceptibility of the knockouts to high-fat
diet induced atherosclerosis.
Our results showed that the L13a knockout mice in the ApoE-/- background suffered
from more severe atherosclerosis than the controls in the same background. The
knockouts also displayed higher atherosclerotic plaque formation in both the aortic sinus
and the entire aorta (Basu et al., 2014). The increase in atherosclerotic lesion formation
was not due to higher cholesterol uptake by the macrophages or higher levels of plasma
cholesterol in the high-fat diet fed knockout mice. The lesion size was also found to be
enlarged in the knockouts. The deficiency of L13a in the macrophages in the knockout
mice led to infiltration of macrophages and neutrophils in the initimal plaque regions
together with disruption of the smooth muscle cells (SMC) layer in the media.
Breakdown and thinning of the SMC layer are characteristic features of atherosclerosis
(Campbell et al., 2012). Current finding in the field suggest that certain matrix-degrading
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metalloproteinases synthesized by macrophages can contribute toward the damage of the
smooth muscle cell layer and facilate their migration toward the initima layer (Newby,
2006). Our research till date has not identified any matrix metalloproteinase as direct
targets of the L13a mediated GAIT silencing pathway. On the other hand, we have
pinpointed CCL3 as one of the targets of the translational silencing mechanism. Research
from other laboratories has suggested that CCL3 can be actively involved in governing
neutrophil migration into the atherosclerotic plaques (de Jager et al., 2013). In agreement
with the previous studies, our results showed increased steady state levels of CCL3 in the
plasma of the high-fat diet fed knockouts mice (Basu et al., 2014).
Findings from other laboratories have indicated the importance of Gr-1 positive
Ly6Chi inflammatory monocytes have important functions in progression of several
inflammatory diseases (Serbina et al., 2008). Also, they have the ability to differentiate
into macrophages which subsequently infiltrate into the atherosclerotic plaques
(Combadiere et al., 2008, Woollard and Geissmann, 2010). Our results in the
atherosclerosis study have demonstrated increased abundance of Gr-1-Ly6Chi
inflammatory monocytes in circulation and highly inflammatory Gr-1/Mac2 double
positive macrophages in the peritoneum of the high-fat diet fed KO mice in comparison
to the controls (Basu et al., 2014). We have also detected increased synthesis of some of
the L13a-dependent GAIT pathway target chemokines (CCL11, CCL3 and CCL22) in the
cells of the aorta and in circulation of the knockout mice. Macrophages harvested from
the high-fat diet fed L13a knockout mice also demonstrated increased polysomal
abundance of several of mRNAs (CCL22, CXCL13 and CCR3) which under the
regulation of the L13a translation silencing pathway (Basu et al., 2014). These findings
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implicate a potential role of the L13a-dependent GAIT mediated translational silencing
mechanism in determining severity of atherosclerosis progression.
The high-fat-diet-induced atherosclerotic study in the KO mice therefore identifies an
endogenous athero-protective role of ribosomal protein L13a. This additional extraribosomal function of L13a is coupled with its role in translational control of a group of
genes implicated in inflammation. This is important in the aspect that such coordinated
and unanimous action of several molecules grouped together can lead to the pathogenesis
of several inflammatory diseases, one of which has been studied to be atherosclerosis.
Therefore, targeting of an entire regulatory pathway instead of one individual molecule
can provide efficient means of restricting the progression of chronic inflammatory
diseases.
Emerging studies in the field have reported the active involvement of several microRNAs (miRNAs) in regulating inflammation and contributing to different inflammatory
diseases including inflammatory bowel diseases, tumor progression and cancer (Sonkoly
and Pivarcsi, 2009, Iborra et al., 2012, Tili et al., 2009, Tili et al., 2008). However,
previous findings from our laboratory using in-vitro translation assays with cell-free
rabbit reticulocyte extracts and purified recombinant L13a reconstituted the translational
silencing mechanism. Also, analysis of the functional GAIT element from several target
mRNAs did not reveal any such miRNA binding sites. Therefore we can rule out the
possibility of any direct involvement of miRNAs in regulating GAIT pathway mediated
translational silencing in our knockout murine models.
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Ribosomopathies are a class of diseases occurring due to some defects in ribosome
biogenesis and activity (Narla and Ebert, 2010). A disease called Diamond-Blackfan
anemia which is characterized by anemia, macrocytosis and reticulocytopenia (Lipton
and Ellis, 2009) has been reported to be caused due to mutations in ribosomal proteins
RPS19, RPS24, RPS17 and RPL35A (Gazda et al., 2006, Cmejla et al., 2007, Farrar et
al., 2008). It has been identified that mutations in RPS19 and RPS25 lead to defects in
processing of the 18S rRNA precursor resulting in reduced synthesis of the 40S
ribosomal subunit (Choesmel et al., 2007, Flygare et al., 2007). Haploinsufficiencies of
specific ribosomal proteins has been linked to irregularities in certain distinct steps in
pre-rRNA processing. In this context, recent studies from our laboratory have identified
some important residues which is essential for its binding to the ribosome (Das et al.,
2013). It has also been suggested that incorporation of ribosomal protein L13a into the
90S pre-ribosome is required for rRNA methylation of the 90S complex (Das et al.,
2013). Haploinsufficiency of RPS14 leads to 5q- syndrome (Ebert et al., 2008) whose
characteristic traits include macrocytic anemia, elevated platelet levels with slow
progression to acute myeloid leukemia (AML). In mice, deficiency of RPL38 has been
shown to cause impairment in tissue patterning (Kondrashov et al., 2011). Ribosomal
Haploinsufficiency can also result in impaired ribosome biogenesis and build-up of free
ribosomal proteins that can bind to MDM2, a repressor of p53. This leads to activation of
p53 followed by cell cycle arrest and apoptosis which might progress to anemia
(McGowan et al., 2008). Studies also suggest that abnormal maturation of ribosomal
subunits can retard translation of the globin genes thereby leading to surplus of free heme
and hence anemia (Keel et al., 2008). However, to our knowledge, and based on previous
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data from our laboratory, we have not observed any such defects arising due to L13a
deficiency other than impairment in rRNA methylation (Chaudhuri et al., 2007).
Our studies therefore identify the essential anti-inflammatory protective role of
ribosomal protein L13a mediated translational silencing in controlling physiological
inflammation caused by endotoxemia, DSS-induced colitis and high-fat diet induced
atherosclerosis. Our gene knockout murine model serves as a novel model to study the
uncontrolled inflammation. Any genetic discrepancy in this silencing pathway has the
potential to increase the severity of inflammation and contribute to disease pathogenesis.
Therefore manipulation of this pathway with small molecule can offer novel therapeutic
strategies in future.
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CHAPTER V
CONCLUSION

Inflammation is an adaptive response of the immune system to protect the host against
invading pathogens. But unresolved inflammation can have adverse effects and lead to an
auto-immune attack. Studies over the past several years have focused on the mechanisms
contributing to an inflammatory response, but little is known about those which help in
controlling inflammation. In our study, we have dissected the physiological importance
and the molecular underpinnings of one such recently identified pathways: the L13adependent GAIT-mediated translational silencing mechanism. To address the
physiological importance of this mechanism in resolving inflammation, we have used the
macrophage-specific knockout murine model of ribosomal protein L13a, where the
resolution phase of inflammation is severely compromised. We have used this animal
model to study the role of L13a in three particular diseases covering acute and chronic
inflammation such as LPS-induced endotoxemia, DSS-induce colitis and high-fat dietinduced atherosclerosis. The details of the first two studies have been mentioned in
chapters 2 and 3 of this thesis respectively, and only the results of the atherosclerosis
study has been included in the discussion section in chapter 4. Our results obtained from
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the LPS study show more severe systemic inflammation in the knockout mice in response
to inflammation. These include reduced survival rates, high levels of several markers of
inflammation, infiltration of macrophages in the kidneys, lungs and peritoneum and
abrogation of translational silencing of several chemokine ligands and receptors whose
expression is under the control of the L13-dependent translation silencing pathway. Our
results from the DSS-induced colitis study support the protective role of L13a in the
macrophages against colitis. Significant observations made from this study include severe
colitis and disease activity index, higher mortality rates, disruption of epithelial crypt
morphology and infiltration of macrophages in the colons of the DSS treated knockouts.
Additionally, elevated levels of several pro-inflammatory cytokines and chemokines were
found in the colons and serum of the DSS treated knockout animals, thereby
demonstrating that the knockouts are more susceptible to DSS-induced colitis. Finally,
upon high-fat-diet feeding, the macrophage-specific L13a knockout mice showed higher
atherosclerotic plaque formation in the aorta accompanied by destruction of the smooth
muscle layer, invasion of macrophages in the intimal layers of the plaques and elevated
plasma levels of inflammatory cytokines. This was also followed by increased polysomal
abundance of several GAIT target mRNAs in the macrophages harvested from the highfat-diet fed knockout mice, thus showing a defect in their translation control. Taken
together, our results demonstrate that the genetic depletion of L13a in the macrophages
can increase the susceptibility to several inflammatory diseases like endotoxemia,
atherosclerosis and inflammatory bowel diseases. This occurs possibly due to the
abrogation of translational silencing of several inflammatory genes which are under the
control of L13a-catalyzed translation silencing mechanism. Therefore, the presence of
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L13a in the macrophages can act as a critical checkpoint of physiological inflammation
permitting the resolution of inflammation. Further detailed studies about the molecular
basis of this pathway could lead to the identification of potential target-mediated
modulation of this pathway, which can prevent many acute and chronic inflammatory
diseases.
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